{"gene":"H1-2","run_date":"2026-06-11T12:11:54","timeline":{"discoveries":[{"year":2003,"finding":"Histone H1.2 is released from the nucleus to the cytoplasm in a p53-dependent manner following X-ray irradiation (DNA double-strand breaks), and uniquely among H1 variants, H1.2 (but not other H1 forms) induces cytochrome c release from isolated mitochondria in a Bak-dependent manner, transmitting apoptotic signals from the nucleus to mitochondria.","method":"Subcellular fractionation, isolated mitochondria cytochrome c release assay, H1.2-deficient mice, genetic knockdown/knockout with apoptosis phenotype readouts","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution with isolated mitochondria, genetic KO mouse model, multiple orthogonal methods, replicated across cell types and tissues","pmids":["14505568"],"is_preprint":false},{"year":2003,"finding":"Histone H1.2 is identified as a substrate for denitrase activity; denitrase specifically removes nitrotyrosine from the single tyrosine residue of H1.2 in an enzymatic, time-dependent, heat- and trypsin-sensitive reaction requiring no additional cofactors.","method":"2D-gel electrophoresis, on-blot enzyme assay, recombinant purified H1.2 chemical nitration, in vitro denitrase activity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous in vitro biochemical assay with recombinant protein, single lab, single study","pmids":["12719531"],"is_preprint":false},{"year":2007,"finding":"Upon UV irradiation, histone H1.2 forms a protein complex with APAF-1, CASP-9, and cytochrome c, and in cell-free systems H1.2 triggers activation of CASP-3 and CASP-7 via APAF-1 and CASP-9, acting as a positive regulator of apoptosome formation.","method":"Affinity labeling, mass spectrometry, cell-free caspase activation assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — cell-free reconstitution of complex and functional caspase assay, single lab, single study","pmids":["17618626"],"is_preprint":false},{"year":2008,"finding":"After bleomycin-induced DNA double-strand breaks, histone H1.2 is translocated from the nucleus to mitochondria and co-localizes with Bak in mitochondria, supporting a role in transmitting apoptotic signals.","method":"Western blotting (subcellular fractionation), immunofluorescence co-localization with Bak, MitoCapture mitochondrial permeabilization assay","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct localization by fractionation and imaging, consistent with prior work, single lab","pmids":["17879944"],"is_preprint":false},{"year":2008,"finding":"H1.2 forms a stable complex with cofactors including YB1 and PURα, and ribosomal proteins, that represses p53-dependent, p300-mediated chromatin transcription; H1.2 directly interacts with p53, blocking p300-mediated chromatin acetylation. ChIP and RNAi confirmed recruitment of YB1, PURα, and H1.2 to the Bax promoter is required for repression of p53-induced transcription.","method":"Affinity purification of H1.2 complex, in vitro chromatin transcription assay, Co-IP, ChIP, RNA interference","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — biochemical reconstitution of transcription repression, multiple orthogonal methods (pulldown, ChIP, RNAi, in vitro transcription), single lab","pmids":["18258596"],"is_preprint":false},{"year":2009,"finding":"Phosphorylation of H1.2 at Ser172 co-localizes to DNA replication and transcription sites in HeLa cells, suggesting site-specific phosphorylation of H1.2 is associated with distinct nuclear processes during the cell cycle.","method":"Phospho-specific antibodies, immunofluorescence co-localization in synchronized HeLa cells, kinase inhibitor staurosporine treatment","journal":"Chromosoma","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization experiment with functional context, multiple phospho-sites mapped, single lab","pmids":["19609548"],"is_preprint":false},{"year":2010,"finding":"The nucleosome interaction surface of linker histone H1c (H1.2) is distinct from that of H1(0); the N-terminal domain governs overall binding affinity, while the C-terminal domain alters the chromatin interaction surface of the globular domain, indicating subtypes bind chromatin with intrinsically different orientations.","method":"Site-directed mutagenesis, domain-swap constructs, dual-color FRAP in living cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis combined with live-cell FRAP, multiple domain-swap experiments, functional consequence defined","pmids":["20444700"],"is_preprint":false},{"year":2012,"finding":"DNA-PK phosphorylates H1.2 at T146, which impairs H1.2 binding to p53 and attenuates H1.2-mediated suppression of p53 transactivation; simultaneously, p300-mediated acetylation of p53's C-terminal domain disrupts the p53–H1.2 interaction. Point mutations mimicking these modification states increase p53-induced apoptosis.","method":"In vitro kinase assay, Co-IP, reporter gene assay, apoptosis assay with phospho-mimetic/acetylation-mimetic mutants","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay, mutagenesis, functional apoptosis readout, multiple orthogonal methods, single lab","pmids":["22249259"],"is_preprint":false},{"year":2012,"finding":"The N-terminal and C-terminal domains of linker histone H1c (H1.2) contribute differentially to nucleosome binding: the N-terminal domain determines overall binding affinity, and the C-terminal domain alters the geometry of the globular domain-nucleosome interaction.","method":"Domain-swap and point mutagenesis, dual-color FRAP assay in living cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis and live-cell FRAP with clear functional validation, single lab","pmids":["22334665"],"is_preprint":false},{"year":2013,"finding":"H1.2 stably interacts with Cul4A E3 ubiquitin ligase and PAF1 elongation complexes; this interaction drives H4K31 ubiquitylation, H3K4me3, and H3K79me2 at target genes to potentiate transcription. H1.2 binds the Ser2-phosphorylated form of RNAPII and bridges the Cul4A–PAF1 interaction. Individual knockdown of H1.2, Cul4A, or PAF1 abolishes the corresponding histone marks and reduces target gene transcription.","method":"Co-IP, ChIP, RNA interference knockdown, histone modification analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, ChIP for histone marks, RNAi with defined phenotype, multiple orthogonal methods, single lab","pmids":["24360965"],"is_preprint":false},{"year":2013,"finding":"During mouse rod photoreceptor maturation, H1c (H1.2) levels increase dramatically and contribute to facultative heterochromatin condensation and structural integrity of rod nuclei; triple knockout (H1c/H1e/H1(0)) causes larger nuclei, decreased heterochromatin area, and altered exposure of H3K9me2 marks, indicating H1c establishes facultative heterochromatin territory.","method":"Genetic knockout (triple KO mice), electron microscopy, immunofluorescence, chromatin analysis, nucleosomal repeat length measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with quantitative structural and epigenetic phenotypes, multiple orthogonal methods, single lab","pmids":["23645681"],"is_preprint":false},{"year":2014,"finding":"H1.2 is less abundant than other H1 variants at transcription start sites of inactive genes; promoters enriched in H1.2 tend to be repressed; H1.2 is enriched at low-GC chromosomal domains and lamina-associated domains, showing the most distinct genomic distribution pattern among H1 variants.","method":"ChIP-seq with variant-specific antibodies and HA-tagged H1 variants in breast cancer cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq with two independent approaches (antibody and tagged protein), single lab, multiple variants compared","pmids":["24476918"],"is_preprint":false},{"year":2014,"finding":"H1.2 localizes to the cytoplasm via a mechanism sensitive to the nuclear export inhibitor leptomycin B (LMB) during cytokine withdrawal-induced apoptosis in T-effector cells; H1.2 is found in a complex with proapoptotic mitochondrial Bak, and its cytoplasmic localization is regulated by JNK signaling.","method":"LMB inhibitor treatment, subcellular fractionation, Co-immunoprecipitation with Bak, apoptosis assay","journal":"International journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — Co-IP and localization experiments, pharmacological inhibitor, single lab, single study","pmids":["24688545"],"is_preprint":false},{"year":2015,"finding":"H1.2 is recruited to distinct chromatin regions dependent on EZH2-mediated H3K27me3; the C-terminal tail of H1.2 is required for binding H3K27me3 nucleosomes, and mutations of three H1.2-specific amino acids in the C-terminal domain abrogate binding to H3K27me3 nucleosomes and fail to silence target genes, establishing H3K27me3 as a key mechanism governing H1.2 recruitment.","method":"ChIP, nucleosome binding assay with H3K27me3 nucleosomes, C-terminal tail mutagenesis, gene expression analysis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis with nucleosome binding assay, ChIP, functional transcription readout, multiple orthogonal methods, single lab","pmids":["26581166"],"is_preprint":false},{"year":2016,"finding":"Hormone-activated progesterone receptor recruits BRG1, which interacts with H1.2 to facilitate its deposition and stabilize nucleosome positioning around the TSS at progestin-repressed genes; BRG1 but not the full BAF complex is recruited to these repressed promoters, and H1.2 deposition is required for gene repression.","method":"ChIP, Co-IP, knockdown experiments, genomic positioning analysis in breast cancer cells","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP combined with Co-IP and functional knockdown, single lab, multiple orthogonal methods","pmids":["27390128"],"is_preprint":false},{"year":2017,"finding":"H1.2 overexpression in retinal cells upregulates SIRT1 and HDAC1 to maintain deacetylation of H4K16, leading to upregulation of ATG proteins and promotion of autophagy. AAV-mediated H1.2 overexpression in retinas increases autophagy, inflammation, and neuron loss; siRNA knockdown attenuates diabetes-induced autophagy and retinal pathology.","method":"Overexpression and knockdown in cell lines, AAV-mediated in vivo overexpression, siRNA knockdown in diabetic mice, Western blotting, immunofluorescence","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple in vitro and in vivo experiments with defined molecular pathway (SIRT1/HDAC1/H4K16ac/ATG), single lab","pmids":["28409999"],"is_preprint":false},{"year":2017,"finding":"H1.2 is a major interaction partner of the retinoblastoma tumor suppressor pRb; H1.2 and pRb form a chromatin-bound complex on E2F target genes, H1.2 augments global pRb association with chromatin, enhances pRb-mediated transcriptional repression of E2F target genes, and facilitates pRb-dependent cell-cycle arrest.","method":"Co-IP, ChIP-seq for genome-wide pRb distribution, knockdown, cell proliferation assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, genome-wide ChIP-seq, knockdown with functional cell-cycle phenotype, single lab, multiple orthogonal methods","pmids":["28614707"],"is_preprint":false},{"year":2018,"finding":"H1.2 directly interacts with the ATM HEAT repeat domain and inhibits MRN complex-dependent ATM recruitment, preventing aberrant ATM activation. Upon DNA damage, PARP1-mediated poly-ADP-ribosylation (PARylation) of the H1.2 C-terminus causes its rapid chromatin dissociation followed by proteasomal degradation; blocking H1.2 displacement via PARP1 depletion or PARylation-dead mutation impairs ATM activation and DNA damage repair.","method":"Co-IP, in vitro binding assay (H1.2–ATM HEAT domain), PARylation assay, PARP1 depletion, H1.2 PARylation-dead mutant, DNA damage repair assays","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct binding assay, mutagenesis, PARP1 depletion, multiple orthogonal methods, mechanistic pathway established","pmids":["29844578"],"is_preprint":false},{"year":2018,"finding":"H1.2 is a novel component of nucleolar organizer regions (NORs); during mitosis H1.2 and UBF are co-recruited to NORs, identified by UBF-Sepharose pulldown. Inhibiting rRNA synthesis in interphase induces NOR-like structures containing both UBF and H1.2; NORs isolated from fragmented chromosomes remain intact and contain both proteins.","method":"UBF-Sepharose affinity pulldown, immunofluorescence co-localization during mitosis, inhibition of rRNA synthesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — pulldown combined with imaging under multiple conditions, single lab","pmids":["29301938"],"is_preprint":false},{"year":2018,"finding":"mH2A1.2 directly interacts with HP1α and H1.2 to maintain the inactive state of the lymphotoxin beta (LTβ) gene in prostate cancer cells; H1.2 has intrinsic ability to inhibit osteoclast differentiation in a mH2A1.2-dependent manner.","method":"Co-IP, ChIP, knockdown functional assays, osteoclastogenesis assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and functional knockdown, single lab, mechanistic pathway defined","pmids":["29925860"],"is_preprint":false},{"year":2019,"finding":"AKT phosphorylates ITCH at Ser257, leading to its nuclear translocation and ITCH-mediated polyubiquitination of H1.2; this polyubiquitination suppresses RNF8/RNF168-dependent 53BP1 foci formation, impairing the DNA damage response. Impaired ITCH nuclear translocation or H1.2 polyubiquitination sensitizes cells to replication stress.","method":"Co-IP, ubiquitination assay, 53BP1 foci immunofluorescence, AKT inhibitor, knockdown/overexpression","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination assay, imaging of DDR foci, pharmacological and genetic perturbations, single lab, multiple orthogonal methods","pmids":["30517763"],"is_preprint":false},{"year":2020,"finding":"Loss of H1.2 (and H1.4) in PLB-985 cells induces an eosinophil-like transcriptional program, negatively regulating neutrophil lineage differentiation; this effect was confirmed in murine bone marrow stem cells, demonstrating a subtype-specific role for H1.2 in granulopoiesis.","method":"Genome-wide CRISPR/Cas9 screen, systematic H1 subtype KO, transcriptomic analysis, differentiation assays in human and mouse cells","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR KO in human cell line and murine model, genome-wide screen, transcriptional and functional differentiation readouts, single lab","pmids":["32391789"],"is_preprint":false},{"year":2020,"finding":"The C-terminal domain (CTD) of H1.2, specifically the K/RVVKP motif, directly interacts with BAK and stimulates mitochondrial cytochrome c release in vitro in a mitochondrial permeability transition-independent manner; substitution of a single valine with threonine in the K/RVVKP motif abolishes cytochrome c release.","method":"In vitro mitochondrial cytochrome c release assay, mutagenesis of K/RVVKP motif, direct binding assay with recombinant BAK, synthetic peptide competition","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis, direct binding assay, mechanistic residue identified, single lab","pmids":["32786407"],"is_preprint":false},{"year":2020,"finding":"K-Ras-ERK1/2 signaling inhibits H1.2 phosphorylation at T146 through MDM2-mediated proteasomal degradation of DNA-PK; H1.2 T146 phosphorylation regulates transcription of downstream genes (NT5E, GDF15, CARD16, CYR61, IGFBP3, WNT16B) and its loss promotes bladder cancer cell growth and migration.","method":"K-Ras mutant transfection, Western blot, ChIP, MTT/colony/transwell assays, qRT-PCR, phospho-mimetic mutation (T146E)","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — ChIP with phospho-mimetic mutant, multiple functional assays, mechanistic connection to DNA-PK/MDM2, single lab, single study","pmids":["31032946"],"is_preprint":false},{"year":2020,"finding":"MTA1 promotes proteasomal degradation of DNA-PK (via MDM2 E3 ligase), thereby reducing DNA-PK-mediated phosphorylation of H1.2 at T146; ectopic expression of H1.2 T146ph rescues MTA1-induced HCC cell growth and migration. NOTE: The corresponding paper (PMID 32435614) was subsequently retracted (PMID 42211522).","method":"Western blot, ChIP, proteasome inhibitor rescue, MDM2 knockout, H1.2 T146ph overexpression — RETRACTED","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 2–3 / Weak — paper subsequently retracted; findings should not be relied upon","pmids":["32435614","42211522"],"is_preprint":false},{"year":2022,"finding":"H1.2 regulates STAT3 activation in HCC; mechanistically, H1.2 and STAT3 form a feed-forward loop in which H1.2 promotes STAT3 activation and STAT3 transcriptionally upregulates H1.2 by binding its promoter; disrupting this loop by STAT3 knockdown or inhibitors rescues H1.2 overexpression-induced proliferation.","method":"Overexpression/knockdown in HCC cell lines, ChIP for STAT3 at H1.2 promoter, in vivo KO/KD mouse models, STAT3 inhibitor treatment","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, genetic KO/KD, pharmacological inhibition, in vivo model, single lab","pmids":["35294987"],"is_preprint":false},{"year":2023,"finding":"H1.2 interacts with NRF2 and enhances its nuclear level and stability, promoting NRF2 binding to the GCLC promoter and consequent transcription, thereby sustaining glutathione synthesis; NRF2 also transcriptionally upregulates H1.2, forming a feed-forward antioxidant cycle that promotes NSCLC progression and chemoresistance.","method":"Co-IP (H1.2–NRF2 interaction), ChIP (NRF2 at GCLC promoter), H1c KO mouse crossed with Kras NSCLC model, ROS/GSH measurement, cisplatin sensitivity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, genetic KO in vivo model, multiple functional readouts, single lab, multiple orthogonal methods","pmids":["37729198"],"is_preprint":false},{"year":2023,"finding":"H1.2 binds to the promoter of Il10rα (encoding an IL-10 receptor subunit) and positively regulates its expression to suppress thermogenesis in beige adipocytes; adipocyte-specific H1.2 knockout promotes iWAT browning and cold tolerance, while Il10rα overexpression negates these effects.","method":"Adipocyte-specific H1.2 KO mice (H1.2AKO), ChIP (H1.2 at Il10rα promoter), overexpression of Il10rα in iWAT, cold tolerance and metabolic phenotyping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO, ChIP, rescue experiment with Il10rα overexpression, multiple in vivo phenotypes, single lab","pmids":["37414781"],"is_preprint":false},{"year":2023,"finding":"H1.2 directly binds to the p16 promoter to repress its transcription; YB-1, a component of the H1.2 complex, positively regulates H1.2 expression levels, and its silencing decreases H1.2 binding at the p16 promoter.","method":"siRNA knockdown, ChIP assay, qRT-PCR, immunoblotting","journal":"Anticancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — ChIP with knockdown, single lab, single study","pmids":["37500167"],"is_preprint":false},{"year":2024,"finding":"ALS-associated mutant FUS (FUSP525L) shows increased interaction with PARP1, promoting PARylation and binding of FUS to histone H1.2; inhibiting PARylation or reducing H1.2 levels alleviates mutant FUS aggregation, stress granule alterations, and apoptosis in iPSC-derived motor neurons; elevated H1.2 worsens FUS-ALS phenotypes driven by its intrinsically disordered terminal domains; knockdown of H1.2 and PARP1 orthologs in C. elegans also decreases FUSP525L aggregation.","method":"Interactome of FUSP525L in iPSC-derived motor neurons, PARP1 inhibition, H1.2 knockdown/overexpression, C. elegans models, aggregation and apoptosis assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — iPSC-derived human neurons plus C. elegans model, interactome, multiple genetic and pharmacological perturbations, replicated across species","pmids":["39167487"],"is_preprint":false},{"year":2024,"finding":"Site-specifically ubiquitylated and acetylated H1.2 in intact chromatosomes show distinct proteome-wide interactomes; chromatin-bound H1.2 recruits proteins involved in DNA double-strand break repair, validated by in vitro ligation assay, and post-translational modifications of H1.2 alter these interactions on a proteome-wide scale.","method":"Chemical biology assembly of site-specifically modified chromatosomes, affinity enrichment mass spectrometry, in vitro ligation assay for DSB repair","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution of modified chromatosomes, proteome-scale MS interactome, functional validation by in vitro assay, single lab","pmids":["37994785"],"is_preprint":false},{"year":2024,"finding":"H1.2 overexpression inhibits EMCV replication by enhancing MDA5-mediated IFN-β signaling; H1.2 interacts with MDA5 and IRF3 during EMCV infection, upregulates MDA5 pathway proteins, and facilitates EMCV-induced phosphorylation and nuclear translocation of IRF3.","method":"Overexpression/knockdown in HEK293T, Co-IP (H1.2 with MDA5 and IRF3), viral plaque/RT-PCR assays, IFN-β reporter assay, IRF3 phosphorylation and localization","journal":"Viruses","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — Co-IP, overexpression/knockdown, functional antiviral assays, single lab, single study","pmids":["38399950"],"is_preprint":false},{"year":2024,"finding":"H1.2 directly interacts with HIF-1α PAS domains and promotes HIF-1α stability and its dimerization with HIF-1β, enhancing HIF-1α transcriptional activity; H1.2 expression is negatively regulated by PARP1 (its inhibitor), and higher H1.2 in naked mole rat cells contributes to anoxic adaptation.","method":"Co-IP (H1.2–HIF-1α), H1.2 overexpression in fibroblasts, HIF-1α dimerization assay, PARP1 inhibition, H1.2 knock-in mouse model with hypoxia challenge","journal":"PLoS biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, functional dimerization assay, engineered KI mouse, single lab","pmids":["39178313"],"is_preprint":false},{"year":2024,"finding":"H1.2 universally localizes to the nuclear periphery and co-localizes with compacted DNA in all human cell lines examined; H1.2 knockdown, alone or combined, triggers global chromatin decompaction, demonstrating a variant-specific role in maintaining peripheral chromatin compaction.","method":"Super-resolution microscopy, immunofluorescence imaging of H1 variants, H1.2 siRNA knockdown with chromatin compaction readout","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — super-resolution imaging across multiple cell lines, knockdown with quantitative chromatin decompaction phenotype, multiple variants compared, single lab","pmids":["38530350"],"is_preprint":false},{"year":2006,"finding":"C-terminal fragments of histone H1.2 are endogenous furin inhibitors purified from porcine liver; the inhibitory activity resides in the C-terminal lysine-rich domain, with Ki values ~2×10⁻⁷ M; full-length H1.2 inhibits furin with lower activity; a 36 amino acid peptide containing the reactive site retains inhibitory activity.","method":"Purification by chromatography from porcine liver, furin inhibition assay (Ki determination), gene cloning and sequencing, synthetic peptide assay","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — biochemical purification and kinetic assay, domain mapping, single lab, single study","pmids":["16956366"],"is_preprint":false},{"year":2015,"finding":"PARP-1 binds the EPHX1 proximal promoter and histone H1.2 (complexed with Aly) binds a regulatory intron 1 site to regulate EPHX1 transcription; mutations at the H1.2-binding site in the Amish population reduce EPHX1 expression and are associated with hypercholanemia.","method":"Biotinylated oligonucleotide pulldown with mass spectrometry, reporter gene assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — oligonucleotide pulldown with MS identification, reporter assay, single lab","pmids":["25992604"],"is_preprint":false},{"year":2026,"finding":"H1.2 inhibits cGAS by affecting the activity of cGAS Lys240, promoting cGAS binding to chromatin (inactivating it), and by recruiting TRIM28 to degrade cGAS in the nucleus; HSV-1 infection downregulates H1.2 by reducing Sp1 mRNA levels, allowing cGAS release and IFN-I activation.","method":"Overexpression/knockdown of H1.2 in HSV-1 infection model, Co-IP (H1.2 with cGAS/TRIM28), cGAS Lys240 activity assay, Sp1 inhibitor (plicamycin) in vivo, IFN-β reporter assay","journal":"mBio","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, functional IFN assay, in vivo plicamycin treatment, mechanistic pathway defined, single lab","pmids":["41972757"],"is_preprint":false},{"year":2025,"finding":"Galectin-1 (Gal-1) interacts with both PARP1 and H1.2 in lung cancer cells; upon etoposide-induced DSBs, Gal-1 enhances H1.2 interaction with PARP1 and accelerates H1.2 PARylation and degradation, which activates downstream ATM and NBS1 DNA repair signaling and reduces apoptosis.","method":"Proximity-labeling proteomics, Co-IP, etoposide treatment, H1.2 PARylation assay, ATM/NBS1 phosphorylation, Gal-1 overexpression/knockdown, in vivo tumor model","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — proximity-labeling proteomics and Co-IP, multiple functional assays, in vivo xenograft, single lab","pmids":["40365664"],"is_preprint":false},{"year":2025,"finding":"SETDB1 binds to SUMOylated histone H1.2 (and H1.4), and SUMOylated H1.2 co-localizes with H3K9me3 at repetitive regions of the genome.","method":"PLAMseq (TurboID proximity-labeling + ChIP-seq), mass spectrometry, western blot validation","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — proximity-labeling (not direct Co-IP), preprint, single lab, single study","pmids":[],"is_preprint":true},{"year":2025,"finding":"The majority of H1.2 behaves like a liquid ('glue') inside chromatin domains, mediating dynamic multivalent electrostatic interactions between nucleosomes rather than binding stably; rapid depletion of H1.2 leads to decondensed chromatin domains both in cells and in molecular dynamics simulations.","method":"Single-molecule live-cell imaging (PALM/SPT), multiscale molecular dynamics simulations, rapid H1.2 depletion with chromatin domain decompaction assay","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — single-molecule imaging plus MD simulation plus functional depletion, preprint, single lab","pmids":[],"is_preprint":true},{"year":2025,"finding":"m6A modification of H1-2 mRNA promotes its stability through IGF2BP1 binding and enhances its translation through the combined action of IGF2BP1 and hnRNPD, providing a post-transcriptional regulatory mechanism for H1.2 expression.","method":"MeRIP-seq, m6A inhibition, siRNA-mediated depletion of m6A readers (YTHDF2, IGF2BP1, hnRNPD), mRNA stability and translation assays","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, mechanistic pathway for H1.2 mRNA regulation but functional consequence on H1.2 protein activity not directly tested","pmids":[],"is_preprint":true},{"year":2026,"finding":"USP7 deubiquitinase interacts with histone H1.2 and protects it from proteasome-mediated degradation; USP7-H1.2 interaction facilitates DNA repair in pancreatic neuroendocrine neoplasm cells.","method":"Proteomics, ubiquitin-omics, Co-IP, comet assay, γ-H2AX immunofluorescence, USP7 inhibitor (P005091), xenograft model","journal":"Science China. Life sciences","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, functional DNA repair assays, in vivo model, single lab","pmids":["41639524"],"is_preprint":false}],"current_model":"Histone H1.2 is a multifunctional linker histone that, beyond its structural role in chromatin compaction (acting as a dynamic liquid-like glue via multivalent electrostatic interactions), functions as a context-dependent gene-specific regulator: it represses transcription by forming complexes with YB1/PURα, binding p53 to block p300-mediated chromatin acetylation, interacting with pRb on E2F target genes, and recognizing EZH2-mediated H3K27me3 via its C-terminal tail; it also acts as a transactivator by bridging Cul4A and PAF1 to drive H4K31 ubiquitylation and productive elongation. In response to DNA double-strand breaks, H1.2 is released from chromatin in a p53-dependent manner (facilitated by PARP1-mediated PARylation and subsequent proteasomal degradation), translocates to the cytoplasm and mitochondria, and directly activates BAK through its C-terminal K/RVVKP motif to trigger cytochrome c release and apoptosis; it also forms an apoptosome complex with APAF-1 and CASP-9. DNA-PK phosphorylates H1.2 at T146 to dampen its repressive and pro-apoptotic activities, while ITCH E3-ligase polyubiquitinates H1.2 to suppress 53BP1-dependent DDR. H1.2 also participates in innate immunity by negatively regulating cGAS (recruiting TRIM28 for its degradation) and positively modulating MDA5/IRF3 signaling, and its genomic distribution is concentrated at low-GC, lamina-associated, H3K27me3-enriched heterochromatic domains."},"narrative":{"mechanistic_narrative":"Histone H1.2 is a linker histone that functions both as a structural organizer of chromatin and as a context-dependent regulator of transcription, the DNA-damage response, and apoptosis [PMID:14505568, PMID:38530350]. As a structural protein it universally localizes to the nuclear periphery and is enriched at low-GC, lamina-associated, H3K27me3-marked heterochromatic domains, where its depletion triggers global chromatin decompaction [PMID:24476918, PMID:38530350], and it establishes facultative heterochromatin in differentiating cells [PMID:23645681]. Its N-terminal domain sets nucleosome-binding affinity while its C-terminal tail dictates the geometry of the globular-domain interaction and reads EZH2-deposited H3K27me3 to direct gene-specific recruitment and silencing [PMID:22334665, PMID:26581166]. H1.2 represses transcription through several routes: it assembles a YB1/PURα-containing complex that binds p53 and blocks p300-mediated chromatin acetylation at the Bax promoter [PMID:18258596], forms a chromatin-bound complex with pRb to repress E2F target genes and enforce cell-cycle arrest [PMID:28614707], and is deposited by BRG1 to silence progestin-repressed genes [PMID:27390128]; conversely, it can act as a transactivator by binding Ser2-phosphorylated RNAPII and bridging the Cul4A E3 ligase and PAF1 elongation complex to drive H4K31 ubiquitylation and productive elongation [PMID:24360965]. In response to DNA double-strand breaks, H1.2 is released from chromatin in a p53-dependent manner—facilitated by PARP1-mediated PARylation of its C-terminus and proteasomal turnover—and translocates to mitochondria where its C-terminal K/RVVKP motif directly activates BAK to release cytochrome c, and it further nucleates an APAF-1/CASP-9 apoptosome to drive apoptosis [PMID:14505568, PMID:29844578, PMID:32786407, PMID:17618626]. This activity is tuned by post-translational control: DNA-PK phosphorylates H1.2 at T146 to weaken p53 binding and dampen its repressive and pro-apoptotic functions [PMID:22249259], while ITCH-mediated polyubiquitination of H1.2 suppresses RNF8/RNF168-dependent 53BP1 foci [PMID:30517763]. H1.2 also stabilizes the transcription factors NRF2 and HIF-1α to support antioxidant and hypoxic adaptive programs [PMID:37729198, PMID:39178313], and contributes to innate antiviral responses by potentiating MDA5/IRF3 signaling while negatively regulating cGAS via TRIM28-mediated degradation [PMID:38399950, PMID:41972757].","teleology":[{"year":2003,"claim":"Established that a linker histone is not merely structural but can transmit a nuclear DNA-damage signal to mitochondria, defining H1.2 as a specific apoptotic effector distinct from other H1 variants.","evidence":"Subcellular fractionation, isolated-mitochondria cytochrome c release, and H1.2-deficient mice after X-ray irradiation","pmids":["14505568"],"confidence":"High","gaps":["Molecular mechanism of Bak engagement not resolved at this stage","How p53 directs H1.2 nuclear release left undefined"]},{"year":2003,"claim":"Identified H1.2 as a substrate of denitrase activity, a biochemical observation about its single tyrosine that remains peripheral to its chromatin functions.","evidence":"In vitro denitrase activity assay on chemically nitrated recombinant H1.2","pmids":["12719531"],"confidence":"Medium","gaps":["Physiological relevance of H1.2 nitration/denitration not established","Single in vitro study without cellular validation"]},{"year":2007,"claim":"Extended H1.2's apoptotic role beyond Bak by showing it positively regulates apoptosome assembly downstream of cytochrome c.","evidence":"Affinity labeling, mass spectrometry, and cell-free caspase activation reconstituting an H1.2/APAF-1/CASP-9/cytochrome c complex after UV","pmids":["17618626"],"confidence":"Medium","gaps":["Single cell-free study without in vivo confirmation","Stoichiometry and direct binding interface with APAF-1 unresolved"]},{"year":2008,"claim":"Defined H1.2 as a sequence-specific transcriptional repressor of the p53 program by reconstituting an inhibitory complex that blocks p300 acetylation.","evidence":"Affinity purification of an H1.2/YB1/PURα complex, in vitro chromatin transcription, Co-IP, and ChIP/RNAi at the Bax promoter","pmids":["18258596"],"confidence":"High","gaps":["How the same protein switches between repressor and apoptotic effector not addressed","Genome-wide scope of YB1/PURα-dependent repression unknown"]},{"year":2008,"claim":"Provided in-cell evidence that H1.2 physically relocates to mitochondria and partners with Bak after DSBs, linking the 2003 release event to its mitochondrial target.","evidence":"Subcellular fractionation, Bak co-localization, and mitochondrial permeabilization assay after bleomycin","pmids":["17879944"],"confidence":"Medium","gaps":["Direct binding residues not mapped","Single-lab imaging-based localization"]},{"year":2010,"claim":"Resolved why H1 subtypes are non-redundant by showing H1.2 has an intrinsically distinct nucleosome-binding orientation governed by separable N- and C-terminal contributions.","evidence":"Domain-swap and point mutagenesis with dual-color FRAP in living cells","pmids":["20444700","22334665"],"confidence":"High","gaps":["Structural basis of the altered globular-domain geometry not solved","Functional consequence for specific target genes not tested here"]},{"year":2009,"claim":"Mapped cell-cycle-coupled phosphorylation of H1.2, hinting that PTMs target it to replication and transcription sites.","evidence":"Phospho-specific antibodies and immunofluorescence in synchronized HeLa cells","pmids":["19609548"],"confidence":"Medium","gaps":["Responsible kinase not identified","Functional output of Ser172 phosphorylation undefined"]},{"year":2012,"claim":"Identified DNA-PK phosphorylation of H1.2 at T146 as a molecular switch that disrupts the p53–H1.2 interaction and de-represses p53-driven apoptosis.","evidence":"In vitro kinase assay, Co-IP, reporter assays, and apoptosis readouts with phospho-/acetylation-mimetic mutants","pmids":["22249259"],"confidence":"High","gaps":["In vivo regulation of T146 phosphorylation not established","Crosstalk with the mitochondrial apoptotic function not examined"]},{"year":2013,"claim":"Showed H1.2 can act as a transactivator, bridging Cul4A and PAF1 to deposit elongation-promoting histone marks, demonstrating a positive role opposite to its repressive activities.","evidence":"Reciprocal Co-IP, ChIP for H4K31ub/H3K4me3/H3K79me2, and RNAi of H1.2/Cul4A/PAF1","pmids":["24360965"],"confidence":"High","gaps":["What determines repressor-versus-activator mode at a given locus unknown","Direct catalytic relationship to Cul4A ubiquitylation not defined"]},{"year":2013,"claim":"Demonstrated a developmental structural role: H1.2 builds facultative heterochromatin needed for rod photoreceptor nuclear integrity.","evidence":"Triple-knockout mice with electron microscopy, immunofluorescence, and nucleosomal repeat-length analysis","pmids":["23645681"],"confidence":"High","gaps":["Redundancy with H1e/H1(0) not fully separated","H1.2-specific contribution within the triple KO not isolated"]},{"year":2014,"claim":"Defined H1.2's distinctive genome-wide distribution, anchoring its repressive function to low-GC, lamina-associated heterochromatic domains.","evidence":"ChIP-seq with variant-specific antibodies and HA-tagged variants in breast cancer cells","pmids":["24476918"],"confidence":"High","gaps":["Mechanism targeting H1.2 to LADs not addressed here","Causality between enrichment and repression correlative"]},{"year":2015,"claim":"Identified H3K27me3 recognition by the H1.2 C-terminal tail as the recruitment mechanism explaining its heterochromatin targeting and silencing.","evidence":"ChIP, H3K27me3-nucleosome binding assays, and C-terminal mutagenesis with gene-expression readout","pmids":["26581166"],"confidence":"High","gaps":["Structural mode of tail–H3K27me3 contact not solved","Whether recruitment is direct or EZH2-coupled at all loci unclear"]},{"year":2016,"claim":"Showed targeted H1.2 deposition can be actively directed by a chromatin remodeler (BRG1) downstream of hormone signaling to repress specific promoters.","evidence":"ChIP, Co-IP, and knockdown with nucleosome positioning analysis at progestin-repressed genes","pmids":["27390128"],"confidence":"High","gaps":["Generality beyond progesterone-responsive genes untested","How BRG1 selects H1.2 versus other variants unknown"]},{"year":2017,"claim":"Established H1.2 as a major pRb partner that augments pRb chromatin loading and E2F target repression, linking it directly to cell-cycle control.","evidence":"Reciprocal Co-IP, genome-wide pRb ChIP-seq, knockdown, and proliferation assays","pmids":["28614707"],"confidence":"High","gaps":["Whether H1.2 acts upstream or downstream of pRb phosphorylation unclear","Structural basis of the H1.2–pRb interaction undefined"]},{"year":2017,"claim":"Connected H1.2 to autophagy regulation via a SIRT1/HDAC1–H4K16ac–ATG axis in a disease (diabetic retinopathy) context.","evidence":"Overexpression/knockdown in cells, AAV in vivo overexpression, and siRNA in diabetic mice","pmids":["28409999"],"confidence":"High","gaps":["Direct versus indirect control of SIRT1/HDAC1 not separated","Relevance outside retinal tissue untested"]},{"year":2018,"claim":"Revealed that PARP1-driven PARylation and degradation displaces H1.2 from chromatin to permit ATM activation, recasting H1.2 release as a regulated step in DSB repair signaling.","evidence":"Direct H1.2–ATM HEAT-domain binding, PARylation assay, PARP1 depletion, PARylation-dead mutant, and repair assays","pmids":["29844578"],"confidence":"High","gaps":["Relationship between this displacement and the pro-apoptotic mitochondrial pool not reconciled","PARylation site(s) not precisely mapped"]},{"year":2018,"claim":"Added an interaction-based repression mechanism via the mH2A1.2/HP1α/H1.2 module controlling immune-relevant gene silencing.","evidence":"Co-IP, ChIP, knockdown, and osteoclastogenesis assays in prostate cancer cells","pmids":["29925860"],"confidence":"Medium","gaps":["Single-lab, single-context observation","Direct versus bridged H1.2–mH2A1.2 contact not resolved"]},{"year":2018,"claim":"Placed H1.2 at nucleolar organizer regions with UBF, implicating it in mitotic rDNA chromatin organization.","evidence":"UBF-Sepharose pulldown and imaging during mitosis and after rRNA synthesis inhibition","pmids":["29301938"],"confidence":"Medium","gaps":["Functional role at NORs not tested","Whether interaction is direct unknown"]},{"year":2019,"claim":"Defined ITCH-mediated polyubiquitination of H1.2 as an AKT-controlled brake on 53BP1-dependent DDR signaling.","evidence":"Co-IP, ubiquitination assay, 53BP1 foci imaging, and AKT inhibition","pmids":["30517763"],"confidence":"High","gaps":["Ubiquitination sites on H1.2 not mapped","Integration with PARP1-driven displacement not addressed"]},{"year":2020,"claim":"Pinpointed the K/RVVKP motif as the minimal C-terminal determinant for direct BAK activation and cytochrome c release, providing the structural mechanism for H1.2's apoptotic effector function.","evidence":"In vitro cytochrome c release, K/RVVKP mutagenesis, direct BAK binding, and peptide competition","pmids":["32786407"],"confidence":"High","gaps":["In vivo requirement of the motif not tested","Conformational change induced in BAK not defined"]},{"year":2020,"claim":"Revealed a lineage-specific role for H1.2 in granulopoiesis, where its loss redirects differentiation toward an eosinophil program.","evidence":"Genome-wide CRISPR screen, subtype KO, transcriptomics, and differentiation assays in human and mouse cells","pmids":["32391789"],"confidence":"High","gaps":["Target genes mediating lineage choice not pinpointed","Overlap of H1.2 and H1.4 functions not separated"]},{"year":2020,"claim":"Linked oncogenic K-Ras-ERK signaling to loss of H1.2 T146 phosphorylation via MDM2-mediated DNA-PK degradation, connecting H1.2 PTM control to tumor growth.","evidence":"K-Ras transfection, ChIP, phospho-mimetic mutant, and proliferation/migration assays in bladder cancer cells","pmids":["31032946"],"confidence":"Medium","gaps":["Single-study mechanistic chain","Direct DNA-PK–MDM2 link not biochemically isolated"]},{"year":2022,"claim":"Identified an H1.2–STAT3 feed-forward loop driving hepatocellular carcinoma proliferation.","evidence":"Overexpression/knockdown, STAT3 ChIP at the H1.2 promoter, in vivo models, and STAT3 inhibition","pmids":["35294987"],"confidence":"Medium","gaps":["Mechanism by which H1.2 promotes STAT3 activation undefined","Single-cancer-type context"]},{"year":2023,"claim":"Established H1.2 as a stabilizer of NRF2 that sustains glutathione synthesis, defining a feed-forward antioxidant cycle promoting NSCLC progression and chemoresistance.","evidence":"Co-IP, NRF2 ChIP at GCLC, H1c-KO/Kras mouse model, and ROS/GSH/cisplatin assays","pmids":["37729198"],"confidence":"High","gaps":["Whether H1.2 acts on NRF2 in the nucleus or cytoplasm not fully resolved","Direct binding interface not mapped"]},{"year":2023,"claim":"Demonstrated a metabolic role: H1.2 represses thermogenesis by activating Il10rα transcription in beige adipocytes.","evidence":"Adipocyte-specific KO mice, ChIP at Il10rα, and Il10rα rescue with cold-tolerance phenotyping","pmids":["37414781"],"confidence":"High","gaps":["How H1.2 activates rather than represses this promoter not mechanistically explained","Upstream signals regulating adipocyte H1.2 unknown"]},{"year":2023,"claim":"Added p16 repression by promoter-bound H1.2, with YB-1 sustaining H1.2 levels and recruitment.","evidence":"siRNA knockdown, ChIP, and qRT-PCR","pmids":["37500167"],"confidence":"Medium","gaps":["Single-lab ChIP-based study","Senescence consequences not functionally tested"]},{"year":2024,"claim":"Showed PTM-state of chromatin-bound H1.2 reshapes its proteome-wide interactome, including recruitment of DSB-repair factors.","evidence":"Chemically defined modified chromatosomes, affinity-MS interactomes, and in vitro ligation assay","pmids":["37994785"],"confidence":"High","gaps":["In-cell relevance of identified interactors not validated","Functional repair contribution beyond ligation assay untested"]},{"year":2024,"claim":"Linked H1.2 to ALS pathology: PARylation-dependent FUS–H1.2 binding promotes mutant FUS aggregation and motor-neuron toxicity.","evidence":"iPSC-motor-neuron interactome, PARP1 inhibition, H1.2 perturbation, and C. elegans models","pmids":["39167487"],"confidence":"High","gaps":["Whether H1.2 acts in cytoplasm or via chromatin in this context unclear","Direct FUS–H1.2 contact versus PARP1-bridged not separated"]},{"year":2024,"claim":"Extended H1.2's transcription-factor stabilizing role to HIF-1α, supporting hypoxic adaptation.","evidence":"Co-IP with HIF-1α PAS domains, dimerization assay, PARP1 inhibition, and a knock-in mouse hypoxia challenge","pmids":["39178313"],"confidence":"Medium","gaps":["Direct binding interface not structurally defined","Single-lab mechanistic chain"]},{"year":2024,"claim":"Defined a positive antiviral role through H1.2 potentiation of MDA5/IRF3 signaling against RNA virus infection.","evidence":"Overexpression/knockdown, Co-IP with MDA5 and IRF3, and IFN-β/viral assays","pmids":["38399950"],"confidence":"Medium","gaps":["Direct versus indirect MDA5/IRF3 engagement unclear","Single-study, single-virus context"]},{"year":2024,"claim":"Confirmed H1.2's universal peripheral localization and its causal requirement for global chromatin compaction across cell types.","evidence":"Super-resolution microscopy and siRNA knockdown with quantitative decompaction readout","pmids":["38530350"],"confidence":"High","gaps":["What targets H1.2 to the periphery not addressed","Relationship between compaction and gene-specific repression not bridged"]},{"year":2025,"claim":"Identified Galectin-1 as a modulator that enhances H1.2 PARylation/degradation to favor ATM/NBS1 repair signaling over apoptosis in lung cancer.","evidence":"Proximity-labeling proteomics, Co-IP, PARylation assay, ATM/NBS1 phosphorylation, and in vivo tumor model","pmids":["40365664"],"confidence":"Medium","gaps":["Direct Gal-1–H1.2 binding versus PARP1-mediated bridging unclear","Single-lab study"]},{"year":2026,"claim":"Defined H1.2 as a negative regulator of cGAS, both inactivating it on chromatin and recruiting TRIM28 for its nuclear degradation, with viral suppression of H1.2 unleashing IFN-I.","evidence":"Co-IP with cGAS/TRIM28, cGAS Lys240 activity assay, HSV-1 infection model, and Sp1 inhibition in vivo","pmids":["41972757"],"confidence":"Medium","gaps":["Direct H1.2–cGAS contact versus chromatin-mediated effect not fully separated","Single-study mechanism"]},{"year":2026,"claim":"Identified USP7 as a deubiquitinase that stabilizes H1.2 to support DNA repair, adding a counterweight to ubiquitin-driven H1.2 turnover.","evidence":"Proteomics, ubiquitin-omics, Co-IP, comet/γ-H2AX assays, USP7 inhibition, and xenografts","pmids":["41639524"],"confidence":"Medium","gaps":["DUB site specificity on H1.2 not mapped","Single-tumor-type context"]},{"year":null,"claim":"How H1.2 toggles between mutually opposed roles—structural glue, gene-specific repressor, transactivator, transcription-factor stabilizer, and cytoplasmic apoptotic effector—through its post-translational modification code and localization remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating chromatin and mitochondrial pools","Structural basis of most direct protein interactions undefined","In vivo hierarchy of competing PTMs (T146 phosphorylation, PARylation, ubiquitination, SUMOylation) not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[10,33,39]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[13]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,16,9,26,32]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[22,17,26,32]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[11,27,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,11,16]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[13,33,11]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,3,22]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,12]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,2,22]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[17,20,30,41]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,9,16]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[10,13,33]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[16]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[31,36]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[26,32]}],"complexes":["H1.2-YB1-PURα repressor complex","APAF-1/CASP-9 apoptosome","Cul4A-PAF1 elongation complex","pRb-H1.2 chromatin complex"],"partners":["TP53","BAK1","RB1","PARP1","ATM","NFE2L2","ITCH","USP7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P16403","full_name":"Histone H1.2","aliases":["Histone H1c","Histone H1d","Histone H1s-1"],"length_aa":213,"mass_kda":21.4,"function":"Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber (PubMed:26581166, PubMed:38530350). Histone H1-2 is required for the condensation of nucleosome chains into higher-order structured fibers (PubMed:38530350). Compared to other histone H1 variants, H1-2 plays an essnetial role in nucleosome condensation: its absence leads to global chromatin decompaction, which is not observed when depleting other histone H1 variants (PubMed:38530350). Histone H1-2 also acts as a histone reader: specifically recognizes and binds histone H3 trimethylated at 'lys-27' (H3K27me3) (PubMed:26581166). Histones H1 also promote formation of the H3K27me3 mark by the PRC2/EED-EZH2 complex, possibly by facilitating restoration of H3K27me3 post-replication (PubMed:37429872, PubMed:40516528). Together with histone H1-3, histone H1-2 acts as a regulator of splicing, most specifically exon skipping and intron retention events: histone H1-2 has a high affinity for exons and regulates splicing by affecting RNA polymerase II (RNAPII) elongation (PubMed:37922872). Also acts as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (PubMed:38530350)","subcellular_location":"Nucleus; Nucleus, nucleolus; Chromosome","url":"https://www.uniprot.org/uniprotkb/P16403/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/H1-2","classification":"Not Classified","n_dependent_lines":222,"n_total_lines":1208,"dependency_fraction":0.1837748344370861},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"H2AFZ","stoichiometry":10.0},{"gene":"HIST2H2BE","stoichiometry":10.0},{"gene":"CAPZB","stoichiometry":4.0},{"gene":"HMGA1","stoichiometry":0.2},{"gene":"NECAP1","stoichiometry":0.2},{"gene":"NUCKS1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/H1-2","total_profiled":1310},"omim":[{"mim_id":"617910","title":"LSM11, U7 SMALL NUCLEAR RNA-ASSOCIATED PROTEIN; LSM11","url":"https://www.omim.org/entry/617910"},{"mim_id":"617876","title":"RNA, U7 SMALL NUCLEAR 1; RNU7-1","url":"https://www.omim.org/entry/617876"},{"mim_id":"142710","title":"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER C; HIST1H1C","url":"https://www.omim.org/entry/142710"},{"mim_id":"142709","title":"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER A; HIST1H1A","url":"https://www.omim.org/entry/142709"},{"mim_id":"132810","title":"EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1","url":"https://www.omim.org/entry/132810"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli rim","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/H1-2"},"hgnc":{"alias_symbol":["H1.2","H1s-1","H1c"],"prev_symbol":["H1F2","HIST1H1C"]},"alphafold":{"accession":"P16403","domains":[{"cath_id":"1.10.10.10","chopping":"39-106","consensus_level":"high","plddt":94.7984,"start":39,"end":106}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P16403","model_url":"https://alphafold.ebi.ac.uk/files/AF-P16403-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P16403-F1-predicted_aligned_error_v6.png","plddt_mean":64.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=H1-2","jax_strain_url":"https://www.jax.org/strain/search?query=H1-2"},"sequence":{"accession":"P16403","fasta_url":"https://rest.uniprot.org/uniprotkb/P16403.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P16403/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P16403"}},"corpus_meta":[{"pmid":"14505568","id":"PMC_14505568","title":"Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/14505568","citation_count":274,"is_preprint":false},{"pmid":"17174556","id":"PMC_17174556","title":"The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.","date":"2006","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/17174556","citation_count":206,"is_preprint":false},{"pmid":"16000317","id":"PMC_16000317","title":"The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16000317","citation_count":181,"is_preprint":false},{"pmid":"12719531","id":"PMC_12719531","title":"Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12719531","citation_count":104,"is_preprint":false},{"pmid":"18258596","id":"PMC_18258596","title":"Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18258596","citation_count":97,"is_preprint":false},{"pmid":"28409999","id":"PMC_28409999","title":"Histone HIST1H1C/H1.2 regulates autophagy in the development of diabetic retinopathy.","date":"2017","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/28409999","citation_count":90,"is_preprint":false},{"pmid":"24476918","id":"PMC_24476918","title":"Mapping of six somatic linker histone H1 variants in human breast cancer cells uncovers specific features of H1.2.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24476918","citation_count":84,"is_preprint":false},{"pmid":"19641063","id":"PMC_19641063","title":"Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2009 outbreak in Milwaukee, Wisconsin.","date":"2009","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19641063","citation_count":74,"is_preprint":false},{"pmid":"29844578","id":"PMC_29844578","title":"Destabilization of linker histone H1.2 is essential for ATM activation and DNA damage repair.","date":"2018","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29844578","citation_count":72,"is_preprint":false},{"pmid":"24360965","id":"PMC_24360965","title":"Linker Histone H1.2 cooperates with Cul4A and PAF1 to drive H4K31 ubiquitylation-mediated transactivation.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24360965","citation_count":54,"is_preprint":false},{"pmid":"2613692","id":"PMC_2613692","title":"Human spleen histone H1. Isolation and amino acid sequences of three minor variants, H1a, H1c, and H1d.","date":"1989","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2613692","citation_count":51,"is_preprint":false},{"pmid":"23645681","id":"PMC_23645681","title":"Developmentally regulated linker histone H1c promotes heterochromatin condensation and mediates structural integrity of rod photoreceptors in mouse retina.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23645681","citation_count":49,"is_preprint":false},{"pmid":"26581166","id":"PMC_26581166","title":"Linker histone H1.2 establishes chromatin compaction and gene silencing through recognition of H3K27me3.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26581166","citation_count":45,"is_preprint":false},{"pmid":"22334665","id":"PMC_22334665","title":"N- and C-terminal domains determine differential nucleosomal binding geometry and affinity of linker histone isotypes H1(0) and H1c.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22334665","citation_count":44,"is_preprint":false},{"pmid":"19609548","id":"PMC_19609548","title":"Site-specifically phosphorylated forms of H1.5 and H1.2 localized at distinct regions of the nucleus are related to different processes during the cell cycle.","date":"2009","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/19609548","citation_count":41,"is_preprint":false},{"pmid":"22249259","id":"PMC_22249259","title":"Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22249259","citation_count":40,"is_preprint":false},{"pmid":"15772144","id":"PMC_15772144","title":"Activity of histone H1.2 in infected burn wounds.","date":"2005","source":"The Journal of antimicrobial chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/15772144","citation_count":40,"is_preprint":false},{"pmid":"17879944","id":"PMC_17879944","title":"Histone H1.2 is translocated to mitochondria and associates with Bak in bleomycin-induced apoptotic cells.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17879944","citation_count":35,"is_preprint":false},{"pmid":"16008566","id":"PMC_16008566","title":"Characterization of sequence variations in human histone H1.2 and H1.4 subtypes.","date":"2005","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16008566","citation_count":31,"is_preprint":false},{"pmid":"20444700","id":"PMC_20444700","title":"Nucleosome interaction surface of linker histone H1c is distinct from that of H1(0).","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20444700","citation_count":30,"is_preprint":false},{"pmid":"27390128","id":"PMC_27390128","title":"Hormone-induced repression of genes requires BRG1-mediated H1.2 deposition at target promoters.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27390128","citation_count":30,"is_preprint":false},{"pmid":"17618626","id":"PMC_17618626","title":"Proapoptotic histone H1.2 induces CASP-3 and -7 activation by forming a protein complex with CYT c, APAF-1 and CASP-9.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17618626","citation_count":27,"is_preprint":false},{"pmid":"29925860","id":"PMC_29925860","title":"MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1α and H1.2.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29925860","citation_count":27,"is_preprint":false},{"pmid":"7188252","id":"PMC_7188252","title":"The structural role of histone H1: properties of reconstituted chromatin with various H1 subfractions (H1-1, H1-2, and H1o).","date":"1982","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7188252","citation_count":22,"is_preprint":false},{"pmid":"35087830","id":"PMC_35087830","title":"Molecular and Cellular Functions of the Linker Histone H1.2.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35087830","citation_count":20,"is_preprint":false},{"pmid":"35294987","id":"PMC_35294987","title":"Histone H1.2 promotes hepatocarcinogenesis by regulating signal transducer and activator of transcription 3 signaling.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/35294987","citation_count":20,"is_preprint":false},{"pmid":"18276036","id":"PMC_18276036","title":"The effect of age and the H1c MAPT haplotype on MAPT expression in human brain.","date":"2008","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/18276036","citation_count":20,"is_preprint":false},{"pmid":"30517763","id":"PMC_30517763","title":"ITCH nuclear translocation and H1.2 polyubiquitination negatively regulate the DNA damage response.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30517763","citation_count":20,"is_preprint":false},{"pmid":"25992604","id":"PMC_25992604","title":"Transcription of the Human Microsomal Epoxide Hydrolase Gene (EPHX1) Is Regulated by PARP-1 and Histone H1.2. Association with Sodium-Dependent Bile Acid Transport.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25992604","citation_count":19,"is_preprint":false},{"pmid":"21970987","id":"PMC_21970987","title":"The linker histone H1C contributes to the SCA7 nuclear phenotype.","date":"2011","source":"Nucleus (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21970987","citation_count":18,"is_preprint":false},{"pmid":"18166788","id":"PMC_18166788","title":"Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment.","date":"2008","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/18166788","citation_count":18,"is_preprint":false},{"pmid":"37729198","id":"PMC_37729198","title":"An antioxidant feedforward cycle coordinated by linker histone variant H1.2 and NRF2 that drives nonsmall cell lung cancer progression.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37729198","citation_count":16,"is_preprint":false},{"pmid":"29050254","id":"PMC_29050254","title":"RGS19 upregulates Nm23-H1/2 metastasis suppressors by transcriptional activation via the cAMP/PKA/CREB pathway.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29050254","citation_count":15,"is_preprint":false},{"pmid":"32391789","id":"PMC_32391789","title":"Linker histone H1.2 and H1.4 affect the neutrophil lineage determination.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32391789","citation_count":14,"is_preprint":false},{"pmid":"20484567","id":"PMC_20484567","title":"A histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis.","date":"2010","source":"Clinical and vaccine immunology : CVI","url":"https://pubmed.ncbi.nlm.nih.gov/20484567","citation_count":14,"is_preprint":false},{"pmid":"39167487","id":"PMC_39167487","title":"ALS-FUS mutations cause abnormal PARylation and histone H1.2 interaction, leading to pathological changes.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39167487","citation_count":13,"is_preprint":false},{"pmid":"28614707","id":"PMC_28614707","title":"Linker Histone H1.2 Directs Genome-wide Chromatin Association of the Retinoblastoma Tumor Suppressor Protein and Facilitates Its Function.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28614707","citation_count":12,"is_preprint":false},{"pmid":"15051953","id":"PMC_15051953","title":"Histone H1t is not replaced by H1.1 or H1.2 in pachytene spermatocytes or spermatids of H1t-deficient mice.","date":"2003","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15051953","citation_count":12,"is_preprint":false},{"pmid":"8055927","id":"PMC_8055927","title":"Role of a distal promoter element in the S-phase control of the human H1.2 histone gene transcription.","date":"1994","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8055927","citation_count":12,"is_preprint":false},{"pmid":"37414781","id":"PMC_37414781","title":"Linker histone variant H1.2 is a brake on white adipose tissue browning.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37414781","citation_count":11,"is_preprint":false},{"pmid":"32896099","id":"PMC_32896099","title":"TADs enriched in histone H1.2 strongly overlap with the B compartment, inaccessible chromatin, and AT-rich Giemsa bands.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/32896099","citation_count":11,"is_preprint":false},{"pmid":"29301938","id":"PMC_29301938","title":"The linker histone H1.2 is a novel component of the nucleolar organizer regions.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29301938","citation_count":10,"is_preprint":false},{"pmid":"32435614","id":"PMC_32435614","title":"MTA1 Promotes Hepatocellular Carcinoma Progression by Downregulation of DNA-PK-Mediated H1.2T146 Phosphorylation.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32435614","citation_count":9,"is_preprint":false},{"pmid":"24688545","id":"PMC_24688545","title":"The linker histone h1.2 is an intermediate in the apoptotic response to cytokine deprivation in T-effectors.","date":"2014","source":"International journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24688545","citation_count":9,"is_preprint":false},{"pmid":"38290407","id":"PMC_38290407","title":"The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.","date":"2023","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/38290407","citation_count":8,"is_preprint":false},{"pmid":"14726680","id":"PMC_14726680","title":"Histone, H1.2: another housekeeping protein that kills.","date":"2004","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/14726680","citation_count":6,"is_preprint":false},{"pmid":"16956366","id":"PMC_16956366","title":"The potent inhibitory activity of histone H1.2 C-terminal fragments on furin.","date":"2006","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16956366","citation_count":6,"is_preprint":false},{"pmid":"32786407","id":"PMC_32786407","title":"Linker Histone H1.2 Directly Activates BAK through the K/RVVKP Motif on the C-Terminal Domain.","date":"2020","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32786407","citation_count":5,"is_preprint":false},{"pmid":"31032946","id":"PMC_31032946","title":"Carcinogenic role of K-Ras-ERK1/2 signaling in bladder cancer via inhibition of H1.2 phosphorylation at T146.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31032946","citation_count":5,"is_preprint":false},{"pmid":"38530350","id":"PMC_38530350","title":"Imaging analysis of six human histone H1 variants reveals universal enrichment of H1.2, H1.3, and H1.5 at the nuclear periphery and nucleolar H1X presence.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38530350","citation_count":5,"is_preprint":false},{"pmid":"1867999","id":"PMC_1867999","title":"Histone H1c decreases markedly in postreplicative stages of chicken spermatogenesis.","date":"1991","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/1867999","citation_count":5,"is_preprint":false},{"pmid":"10953318","id":"PMC_10953318","title":"The recombinant human histones H1 zero and H1.2 cause different toxicity profiles on the human leukemia cell line K562.","date":"2000","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10953318","citation_count":5,"is_preprint":false},{"pmid":"37994785","id":"PMC_37994785","title":"Interactome of intact chromatosome variants with site-specifically ubiquitylated and acetylated linker histone H1.2.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/37994785","citation_count":5,"is_preprint":false},{"pmid":"38399950","id":"PMC_38399950","title":"Histone H1.2 Inhibited EMCV Replication through Enhancing MDA5-Mediated IFN-β Signaling Pathway.","date":"2024","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/38399950","citation_count":4,"is_preprint":false},{"pmid":"35743829","id":"PMC_35743829","title":"The Highest Density of Phosphorylated Histone H1 Appeared in Prophase and Prometaphase in Parallel with Reduced H3K9me3, and HDAC1 Depletion Increased H1.2/H1.3 and H1.4 Serine 38 Phosphorylation.","date":"2022","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35743829","citation_count":4,"is_preprint":false},{"pmid":"37869664","id":"PMC_37869664","title":"HMGN2 and Histone H1.2: potential targets of a novel probiotic mixture for seasonal allergic rhinitis.","date":"2023","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37869664","citation_count":3,"is_preprint":false},{"pmid":"39178313","id":"PMC_39178313","title":"Comparative time-series multi-omics analyses suggest H1.2 involvement in anoxic adaptation and cancer resistance.","date":"2024","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/39178313","citation_count":3,"is_preprint":false},{"pmid":"40365664","id":"PMC_40365664","title":"Gal-1 promotes lung cancer cell survival by enhancing PARP1/H1.2 interaction to promote DNA repair upon DNA damage response.","date":"2025","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/40365664","citation_count":3,"is_preprint":false},{"pmid":"37500167","id":"PMC_37500167","title":"Histone H1.2 Represses the Transcription of the p16 Tumor Suppressor Gene.","date":"2023","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37500167","citation_count":2,"is_preprint":false},{"pmid":"29869686","id":"PMC_29869686","title":"Brown Hare's (Lepus europaeus) Histone H1 Variant H1.2 as an Indicator of Anthropogenic Stress.","date":"2018","source":"Archives of environmental contamination and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29869686","citation_count":1,"is_preprint":false},{"pmid":"41972757","id":"PMC_41972757","title":"Linker histone H1.2 inhibits HSV-1-induced IFN response via cGAS.","date":"2026","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/41972757","citation_count":0,"is_preprint":false},{"pmid":"25145348","id":"PMC_25145348","title":"Role of linker histone H1c during the reprogramming of Chinese swamp buffalo (Bubalus Bubalis) embryos produced by somatic cell nuclear transfer.","date":"2016","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/25145348","citation_count":0,"is_preprint":false},{"pmid":"42098859","id":"PMC_42098859","title":"H1.3 depletion in AML cells prompts H1.2 redistribution, chromatin remodeling and cell cycle defects.","date":"2026","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/42098859","citation_count":0,"is_preprint":false},{"pmid":"39796235","id":"PMC_39796235","title":"Anticancer Plant Secondary Metabolites Evicting Linker Histone H1.2 from Chromatin Activate Type I Interferon Signaling.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39796235","citation_count":0,"is_preprint":false},{"pmid":"41639524","id":"PMC_41639524","title":"USP7 protects histone H1.2 from proteasome-mediated degradation to facilitate DNA repair and pancreatic neuroendocrine neoplasms progression.","date":"2026","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41639524","citation_count":0,"is_preprint":false},{"pmid":"42211522","id":"PMC_42211522","title":"Retraction: MTA1 promotes hepatocellular carcinoma progression by downregulation of DNA-PK-mediated H1.2T146 phosphorylation.","date":"2026","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/42211522","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.22.677529","title":"CDCA7 facilitates MET1-mediated CG DNA methylation maintenance in centromeric heterochromatin via histone H1","date":"2025-09-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.22.677529","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.07.687224","title":"Histone H1 Promotes Silencing of Unintegrated HIV-1 DNA","date":"2025-11-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.07.687224","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.03.657682","title":"Linker Histone H1.5 Contributes to Centromere Integrity in Human Cells","date":"2025-06-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.03.657682","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.01.668067","title":"Neurotropic and non-neurotropic equid alphaherpesvirus 1 (EHV1) mobilize most histones within viral replication compartments","date":"2025-08-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.01.668067","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.27.650851","title":"PLAMseq enables the proteo-genomic characterization of chromatin-associated proteins and protein interactions in a single experimental workflow","date":"2025-04-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.27.650851","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.05.641622","title":"Linker histone H1 functions as a liquid-like glue to organize chromatin in living human cells","date":"2025-03-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.05.641622","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.22.634368","title":"Differential regulation of histone H1 subtypes by N6-methyladenosine RNA methylation","date":"2025-01-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.22.634368","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":35639,"output_tokens":10527,"usd":0.132411,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20954,"output_tokens":9011,"usd":0.165022,"stage2_stop_reason":"end_turn"},"total_usd":0.297433,"stage1_batch_id":"msgbatch_01AsKq64opiyvpDv2j3FexYQ","stage2_batch_id":"msgbatch_01XG5TnAVxejxY779cwb2uS8","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Histone H1.2 is released from the nucleus to the cytoplasm in a p53-dependent manner following X-ray irradiation (DNA double-strand breaks), and uniquely among H1 variants, H1.2 (but not other H1 forms) induces cytochrome c release from isolated mitochondria in a Bak-dependent manner, transmitting apoptotic signals from the nucleus to mitochondria.\",\n      \"method\": \"Subcellular fractionation, isolated mitochondria cytochrome c release assay, H1.2-deficient mice, genetic knockdown/knockout with apoptosis phenotype readouts\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution with isolated mitochondria, genetic KO mouse model, multiple orthogonal methods, replicated across cell types and tissues\",\n      \"pmids\": [\"14505568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Histone H1.2 is identified as a substrate for denitrase activity; denitrase specifically removes nitrotyrosine from the single tyrosine residue of H1.2 in an enzymatic, time-dependent, heat- and trypsin-sensitive reaction requiring no additional cofactors.\",\n      \"method\": \"2D-gel electrophoresis, on-blot enzyme assay, recombinant purified H1.2 chemical nitration, in vitro denitrase activity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous in vitro biochemical assay with recombinant protein, single lab, single study\",\n      \"pmids\": [\"12719531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Upon UV irradiation, histone H1.2 forms a protein complex with APAF-1, CASP-9, and cytochrome c, and in cell-free systems H1.2 triggers activation of CASP-3 and CASP-7 via APAF-1 and CASP-9, acting as a positive regulator of apoptosome formation.\",\n      \"method\": \"Affinity labeling, mass spectrometry, cell-free caspase activation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — cell-free reconstitution of complex and functional caspase assay, single lab, single study\",\n      \"pmids\": [\"17618626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"After bleomycin-induced DNA double-strand breaks, histone H1.2 is translocated from the nucleus to mitochondria and co-localizes with Bak in mitochondria, supporting a role in transmitting apoptotic signals.\",\n      \"method\": \"Western blotting (subcellular fractionation), immunofluorescence co-localization with Bak, MitoCapture mitochondrial permeabilization assay\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct localization by fractionation and imaging, consistent with prior work, single lab\",\n      \"pmids\": [\"17879944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"H1.2 forms a stable complex with cofactors including YB1 and PURα, and ribosomal proteins, that represses p53-dependent, p300-mediated chromatin transcription; H1.2 directly interacts with p53, blocking p300-mediated chromatin acetylation. ChIP and RNAi confirmed recruitment of YB1, PURα, and H1.2 to the Bax promoter is required for repression of p53-induced transcription.\",\n      \"method\": \"Affinity purification of H1.2 complex, in vitro chromatin transcription assay, Co-IP, ChIP, RNA interference\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — biochemical reconstitution of transcription repression, multiple orthogonal methods (pulldown, ChIP, RNAi, in vitro transcription), single lab\",\n      \"pmids\": [\"18258596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Phosphorylation of H1.2 at Ser172 co-localizes to DNA replication and transcription sites in HeLa cells, suggesting site-specific phosphorylation of H1.2 is associated with distinct nuclear processes during the cell cycle.\",\n      \"method\": \"Phospho-specific antibodies, immunofluorescence co-localization in synchronized HeLa cells, kinase inhibitor staurosporine treatment\",\n      \"journal\": \"Chromosoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization experiment with functional context, multiple phospho-sites mapped, single lab\",\n      \"pmids\": [\"19609548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The nucleosome interaction surface of linker histone H1c (H1.2) is distinct from that of H1(0); the N-terminal domain governs overall binding affinity, while the C-terminal domain alters the chromatin interaction surface of the globular domain, indicating subtypes bind chromatin with intrinsically different orientations.\",\n      \"method\": \"Site-directed mutagenesis, domain-swap constructs, dual-color FRAP in living cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis combined with live-cell FRAP, multiple domain-swap experiments, functional consequence defined\",\n      \"pmids\": [\"20444700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DNA-PK phosphorylates H1.2 at T146, which impairs H1.2 binding to p53 and attenuates H1.2-mediated suppression of p53 transactivation; simultaneously, p300-mediated acetylation of p53's C-terminal domain disrupts the p53–H1.2 interaction. Point mutations mimicking these modification states increase p53-induced apoptosis.\",\n      \"method\": \"In vitro kinase assay, Co-IP, reporter gene assay, apoptosis assay with phospho-mimetic/acetylation-mimetic mutants\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay, mutagenesis, functional apoptosis readout, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"22249259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The N-terminal and C-terminal domains of linker histone H1c (H1.2) contribute differentially to nucleosome binding: the N-terminal domain determines overall binding affinity, and the C-terminal domain alters the geometry of the globular domain-nucleosome interaction.\",\n      \"method\": \"Domain-swap and point mutagenesis, dual-color FRAP assay in living cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis and live-cell FRAP with clear functional validation, single lab\",\n      \"pmids\": [\"22334665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"H1.2 stably interacts with Cul4A E3 ubiquitin ligase and PAF1 elongation complexes; this interaction drives H4K31 ubiquitylation, H3K4me3, and H3K79me2 at target genes to potentiate transcription. H1.2 binds the Ser2-phosphorylated form of RNAPII and bridges the Cul4A–PAF1 interaction. Individual knockdown of H1.2, Cul4A, or PAF1 abolishes the corresponding histone marks and reduces target gene transcription.\",\n      \"method\": \"Co-IP, ChIP, RNA interference knockdown, histone modification analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, ChIP for histone marks, RNAi with defined phenotype, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"24360965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"During mouse rod photoreceptor maturation, H1c (H1.2) levels increase dramatically and contribute to facultative heterochromatin condensation and structural integrity of rod nuclei; triple knockout (H1c/H1e/H1(0)) causes larger nuclei, decreased heterochromatin area, and altered exposure of H3K9me2 marks, indicating H1c establishes facultative heterochromatin territory.\",\n      \"method\": \"Genetic knockout (triple KO mice), electron microscopy, immunofluorescence, chromatin analysis, nucleosomal repeat length measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with quantitative structural and epigenetic phenotypes, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"23645681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"H1.2 is less abundant than other H1 variants at transcription start sites of inactive genes; promoters enriched in H1.2 tend to be repressed; H1.2 is enriched at low-GC chromosomal domains and lamina-associated domains, showing the most distinct genomic distribution pattern among H1 variants.\",\n      \"method\": \"ChIP-seq with variant-specific antibodies and HA-tagged H1 variants in breast cancer cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq with two independent approaches (antibody and tagged protein), single lab, multiple variants compared\",\n      \"pmids\": [\"24476918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"H1.2 localizes to the cytoplasm via a mechanism sensitive to the nuclear export inhibitor leptomycin B (LMB) during cytokine withdrawal-induced apoptosis in T-effector cells; H1.2 is found in a complex with proapoptotic mitochondrial Bak, and its cytoplasmic localization is regulated by JNK signaling.\",\n      \"method\": \"LMB inhibitor treatment, subcellular fractionation, Co-immunoprecipitation with Bak, apoptosis assay\",\n      \"journal\": \"International journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — Co-IP and localization experiments, pharmacological inhibitor, single lab, single study\",\n      \"pmids\": [\"24688545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"H1.2 is recruited to distinct chromatin regions dependent on EZH2-mediated H3K27me3; the C-terminal tail of H1.2 is required for binding H3K27me3 nucleosomes, and mutations of three H1.2-specific amino acids in the C-terminal domain abrogate binding to H3K27me3 nucleosomes and fail to silence target genes, establishing H3K27me3 as a key mechanism governing H1.2 recruitment.\",\n      \"method\": \"ChIP, nucleosome binding assay with H3K27me3 nucleosomes, C-terminal tail mutagenesis, gene expression analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis with nucleosome binding assay, ChIP, functional transcription readout, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"26581166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hormone-activated progesterone receptor recruits BRG1, which interacts with H1.2 to facilitate its deposition and stabilize nucleosome positioning around the TSS at progestin-repressed genes; BRG1 but not the full BAF complex is recruited to these repressed promoters, and H1.2 deposition is required for gene repression.\",\n      \"method\": \"ChIP, Co-IP, knockdown experiments, genomic positioning analysis in breast cancer cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP combined with Co-IP and functional knockdown, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"27390128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"H1.2 overexpression in retinal cells upregulates SIRT1 and HDAC1 to maintain deacetylation of H4K16, leading to upregulation of ATG proteins and promotion of autophagy. AAV-mediated H1.2 overexpression in retinas increases autophagy, inflammation, and neuron loss; siRNA knockdown attenuates diabetes-induced autophagy and retinal pathology.\",\n      \"method\": \"Overexpression and knockdown in cell lines, AAV-mediated in vivo overexpression, siRNA knockdown in diabetic mice, Western blotting, immunofluorescence\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vitro and in vivo experiments with defined molecular pathway (SIRT1/HDAC1/H4K16ac/ATG), single lab\",\n      \"pmids\": [\"28409999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"H1.2 is a major interaction partner of the retinoblastoma tumor suppressor pRb; H1.2 and pRb form a chromatin-bound complex on E2F target genes, H1.2 augments global pRb association with chromatin, enhances pRb-mediated transcriptional repression of E2F target genes, and facilitates pRb-dependent cell-cycle arrest.\",\n      \"method\": \"Co-IP, ChIP-seq for genome-wide pRb distribution, knockdown, cell proliferation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, genome-wide ChIP-seq, knockdown with functional cell-cycle phenotype, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"28614707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"H1.2 directly interacts with the ATM HEAT repeat domain and inhibits MRN complex-dependent ATM recruitment, preventing aberrant ATM activation. Upon DNA damage, PARP1-mediated poly-ADP-ribosylation (PARylation) of the H1.2 C-terminus causes its rapid chromatin dissociation followed by proteasomal degradation; blocking H1.2 displacement via PARP1 depletion or PARylation-dead mutation impairs ATM activation and DNA damage repair.\",\n      \"method\": \"Co-IP, in vitro binding assay (H1.2–ATM HEAT domain), PARylation assay, PARP1 depletion, H1.2 PARylation-dead mutant, DNA damage repair assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct binding assay, mutagenesis, PARP1 depletion, multiple orthogonal methods, mechanistic pathway established\",\n      \"pmids\": [\"29844578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"H1.2 is a novel component of nucleolar organizer regions (NORs); during mitosis H1.2 and UBF are co-recruited to NORs, identified by UBF-Sepharose pulldown. Inhibiting rRNA synthesis in interphase induces NOR-like structures containing both UBF and H1.2; NORs isolated from fragmented chromosomes remain intact and contain both proteins.\",\n      \"method\": \"UBF-Sepharose affinity pulldown, immunofluorescence co-localization during mitosis, inhibition of rRNA synthesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — pulldown combined with imaging under multiple conditions, single lab\",\n      \"pmids\": [\"29301938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"mH2A1.2 directly interacts with HP1α and H1.2 to maintain the inactive state of the lymphotoxin beta (LTβ) gene in prostate cancer cells; H1.2 has intrinsic ability to inhibit osteoclast differentiation in a mH2A1.2-dependent manner.\",\n      \"method\": \"Co-IP, ChIP, knockdown functional assays, osteoclastogenesis assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and functional knockdown, single lab, mechanistic pathway defined\",\n      \"pmids\": [\"29925860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"AKT phosphorylates ITCH at Ser257, leading to its nuclear translocation and ITCH-mediated polyubiquitination of H1.2; this polyubiquitination suppresses RNF8/RNF168-dependent 53BP1 foci formation, impairing the DNA damage response. Impaired ITCH nuclear translocation or H1.2 polyubiquitination sensitizes cells to replication stress.\",\n      \"method\": \"Co-IP, ubiquitination assay, 53BP1 foci immunofluorescence, AKT inhibitor, knockdown/overexpression\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination assay, imaging of DDR foci, pharmacological and genetic perturbations, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"30517763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Loss of H1.2 (and H1.4) in PLB-985 cells induces an eosinophil-like transcriptional program, negatively regulating neutrophil lineage differentiation; this effect was confirmed in murine bone marrow stem cells, demonstrating a subtype-specific role for H1.2 in granulopoiesis.\",\n      \"method\": \"Genome-wide CRISPR/Cas9 screen, systematic H1 subtype KO, transcriptomic analysis, differentiation assays in human and mouse cells\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO in human cell line and murine model, genome-wide screen, transcriptional and functional differentiation readouts, single lab\",\n      \"pmids\": [\"32391789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The C-terminal domain (CTD) of H1.2, specifically the K/RVVKP motif, directly interacts with BAK and stimulates mitochondrial cytochrome c release in vitro in a mitochondrial permeability transition-independent manner; substitution of a single valine with threonine in the K/RVVKP motif abolishes cytochrome c release.\",\n      \"method\": \"In vitro mitochondrial cytochrome c release assay, mutagenesis of K/RVVKP motif, direct binding assay with recombinant BAK, synthetic peptide competition\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis, direct binding assay, mechanistic residue identified, single lab\",\n      \"pmids\": [\"32786407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"K-Ras-ERK1/2 signaling inhibits H1.2 phosphorylation at T146 through MDM2-mediated proteasomal degradation of DNA-PK; H1.2 T146 phosphorylation regulates transcription of downstream genes (NT5E, GDF15, CARD16, CYR61, IGFBP3, WNT16B) and its loss promotes bladder cancer cell growth and migration.\",\n      \"method\": \"K-Ras mutant transfection, Western blot, ChIP, MTT/colony/transwell assays, qRT-PCR, phospho-mimetic mutation (T146E)\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — ChIP with phospho-mimetic mutant, multiple functional assays, mechanistic connection to DNA-PK/MDM2, single lab, single study\",\n      \"pmids\": [\"31032946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MTA1 promotes proteasomal degradation of DNA-PK (via MDM2 E3 ligase), thereby reducing DNA-PK-mediated phosphorylation of H1.2 at T146; ectopic expression of H1.2 T146ph rescues MTA1-induced HCC cell growth and migration. NOTE: The corresponding paper (PMID 32435614) was subsequently retracted (PMID 42211522).\",\n      \"method\": \"Western blot, ChIP, proteasome inhibitor rescue, MDM2 knockout, H1.2 T146ph overexpression — RETRACTED\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — paper subsequently retracted; findings should not be relied upon\",\n      \"pmids\": [\"32435614\", \"42211522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"H1.2 regulates STAT3 activation in HCC; mechanistically, H1.2 and STAT3 form a feed-forward loop in which H1.2 promotes STAT3 activation and STAT3 transcriptionally upregulates H1.2 by binding its promoter; disrupting this loop by STAT3 knockdown or inhibitors rescues H1.2 overexpression-induced proliferation.\",\n      \"method\": \"Overexpression/knockdown in HCC cell lines, ChIP for STAT3 at H1.2 promoter, in vivo KO/KD mouse models, STAT3 inhibitor treatment\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, genetic KO/KD, pharmacological inhibition, in vivo model, single lab\",\n      \"pmids\": [\"35294987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"H1.2 interacts with NRF2 and enhances its nuclear level and stability, promoting NRF2 binding to the GCLC promoter and consequent transcription, thereby sustaining glutathione synthesis; NRF2 also transcriptionally upregulates H1.2, forming a feed-forward antioxidant cycle that promotes NSCLC progression and chemoresistance.\",\n      \"method\": \"Co-IP (H1.2–NRF2 interaction), ChIP (NRF2 at GCLC promoter), H1c KO mouse crossed with Kras NSCLC model, ROS/GSH measurement, cisplatin sensitivity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, genetic KO in vivo model, multiple functional readouts, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"37729198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"H1.2 binds to the promoter of Il10rα (encoding an IL-10 receptor subunit) and positively regulates its expression to suppress thermogenesis in beige adipocytes; adipocyte-specific H1.2 knockout promotes iWAT browning and cold tolerance, while Il10rα overexpression negates these effects.\",\n      \"method\": \"Adipocyte-specific H1.2 KO mice (H1.2AKO), ChIP (H1.2 at Il10rα promoter), overexpression of Il10rα in iWAT, cold tolerance and metabolic phenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, ChIP, rescue experiment with Il10rα overexpression, multiple in vivo phenotypes, single lab\",\n      \"pmids\": [\"37414781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"H1.2 directly binds to the p16 promoter to repress its transcription; YB-1, a component of the H1.2 complex, positively regulates H1.2 expression levels, and its silencing decreases H1.2 binding at the p16 promoter.\",\n      \"method\": \"siRNA knockdown, ChIP assay, qRT-PCR, immunoblotting\",\n      \"journal\": \"Anticancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — ChIP with knockdown, single lab, single study\",\n      \"pmids\": [\"37500167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ALS-associated mutant FUS (FUSP525L) shows increased interaction with PARP1, promoting PARylation and binding of FUS to histone H1.2; inhibiting PARylation or reducing H1.2 levels alleviates mutant FUS aggregation, stress granule alterations, and apoptosis in iPSC-derived motor neurons; elevated H1.2 worsens FUS-ALS phenotypes driven by its intrinsically disordered terminal domains; knockdown of H1.2 and PARP1 orthologs in C. elegans also decreases FUSP525L aggregation.\",\n      \"method\": \"Interactome of FUSP525L in iPSC-derived motor neurons, PARP1 inhibition, H1.2 knockdown/overexpression, C. elegans models, aggregation and apoptosis assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — iPSC-derived human neurons plus C. elegans model, interactome, multiple genetic and pharmacological perturbations, replicated across species\",\n      \"pmids\": [\"39167487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Site-specifically ubiquitylated and acetylated H1.2 in intact chromatosomes show distinct proteome-wide interactomes; chromatin-bound H1.2 recruits proteins involved in DNA double-strand break repair, validated by in vitro ligation assay, and post-translational modifications of H1.2 alter these interactions on a proteome-wide scale.\",\n      \"method\": \"Chemical biology assembly of site-specifically modified chromatosomes, affinity enrichment mass spectrometry, in vitro ligation assay for DSB repair\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution of modified chromatosomes, proteome-scale MS interactome, functional validation by in vitro assay, single lab\",\n      \"pmids\": [\"37994785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"H1.2 overexpression inhibits EMCV replication by enhancing MDA5-mediated IFN-β signaling; H1.2 interacts with MDA5 and IRF3 during EMCV infection, upregulates MDA5 pathway proteins, and facilitates EMCV-induced phosphorylation and nuclear translocation of IRF3.\",\n      \"method\": \"Overexpression/knockdown in HEK293T, Co-IP (H1.2 with MDA5 and IRF3), viral plaque/RT-PCR assays, IFN-β reporter assay, IRF3 phosphorylation and localization\",\n      \"journal\": \"Viruses\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — Co-IP, overexpression/knockdown, functional antiviral assays, single lab, single study\",\n      \"pmids\": [\"38399950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"H1.2 directly interacts with HIF-1α PAS domains and promotes HIF-1α stability and its dimerization with HIF-1β, enhancing HIF-1α transcriptional activity; H1.2 expression is negatively regulated by PARP1 (its inhibitor), and higher H1.2 in naked mole rat cells contributes to anoxic adaptation.\",\n      \"method\": \"Co-IP (H1.2–HIF-1α), H1.2 overexpression in fibroblasts, HIF-1α dimerization assay, PARP1 inhibition, H1.2 knock-in mouse model with hypoxia challenge\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, functional dimerization assay, engineered KI mouse, single lab\",\n      \"pmids\": [\"39178313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"H1.2 universally localizes to the nuclear periphery and co-localizes with compacted DNA in all human cell lines examined; H1.2 knockdown, alone or combined, triggers global chromatin decompaction, demonstrating a variant-specific role in maintaining peripheral chromatin compaction.\",\n      \"method\": \"Super-resolution microscopy, immunofluorescence imaging of H1 variants, H1.2 siRNA knockdown with chromatin compaction readout\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — super-resolution imaging across multiple cell lines, knockdown with quantitative chromatin decompaction phenotype, multiple variants compared, single lab\",\n      \"pmids\": [\"38530350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"C-terminal fragments of histone H1.2 are endogenous furin inhibitors purified from porcine liver; the inhibitory activity resides in the C-terminal lysine-rich domain, with Ki values ~2×10⁻⁷ M; full-length H1.2 inhibits furin with lower activity; a 36 amino acid peptide containing the reactive site retains inhibitory activity.\",\n      \"method\": \"Purification by chromatography from porcine liver, furin inhibition assay (Ki determination), gene cloning and sequencing, synthetic peptide assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — biochemical purification and kinetic assay, domain mapping, single lab, single study\",\n      \"pmids\": [\"16956366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PARP-1 binds the EPHX1 proximal promoter and histone H1.2 (complexed with Aly) binds a regulatory intron 1 site to regulate EPHX1 transcription; mutations at the H1.2-binding site in the Amish population reduce EPHX1 expression and are associated with hypercholanemia.\",\n      \"method\": \"Biotinylated oligonucleotide pulldown with mass spectrometry, reporter gene assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — oligonucleotide pulldown with MS identification, reporter assay, single lab\",\n      \"pmids\": [\"25992604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"H1.2 inhibits cGAS by affecting the activity of cGAS Lys240, promoting cGAS binding to chromatin (inactivating it), and by recruiting TRIM28 to degrade cGAS in the nucleus; HSV-1 infection downregulates H1.2 by reducing Sp1 mRNA levels, allowing cGAS release and IFN-I activation.\",\n      \"method\": \"Overexpression/knockdown of H1.2 in HSV-1 infection model, Co-IP (H1.2 with cGAS/TRIM28), cGAS Lys240 activity assay, Sp1 inhibitor (plicamycin) in vivo, IFN-β reporter assay\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, functional IFN assay, in vivo plicamycin treatment, mechanistic pathway defined, single lab\",\n      \"pmids\": [\"41972757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Galectin-1 (Gal-1) interacts with both PARP1 and H1.2 in lung cancer cells; upon etoposide-induced DSBs, Gal-1 enhances H1.2 interaction with PARP1 and accelerates H1.2 PARylation and degradation, which activates downstream ATM and NBS1 DNA repair signaling and reduces apoptosis.\",\n      \"method\": \"Proximity-labeling proteomics, Co-IP, etoposide treatment, H1.2 PARylation assay, ATM/NBS1 phosphorylation, Gal-1 overexpression/knockdown, in vivo tumor model\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — proximity-labeling proteomics and Co-IP, multiple functional assays, in vivo xenograft, single lab\",\n      \"pmids\": [\"40365664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SETDB1 binds to SUMOylated histone H1.2 (and H1.4), and SUMOylated H1.2 co-localizes with H3K9me3 at repetitive regions of the genome.\",\n      \"method\": \"PLAMseq (TurboID proximity-labeling + ChIP-seq), mass spectrometry, western blot validation\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — proximity-labeling (not direct Co-IP), preprint, single lab, single study\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The majority of H1.2 behaves like a liquid ('glue') inside chromatin domains, mediating dynamic multivalent electrostatic interactions between nucleosomes rather than binding stably; rapid depletion of H1.2 leads to decondensed chromatin domains both in cells and in molecular dynamics simulations.\",\n      \"method\": \"Single-molecule live-cell imaging (PALM/SPT), multiscale molecular dynamics simulations, rapid H1.2 depletion with chromatin domain decompaction assay\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — single-molecule imaging plus MD simulation plus functional depletion, preprint, single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"m6A modification of H1-2 mRNA promotes its stability through IGF2BP1 binding and enhances its translation through the combined action of IGF2BP1 and hnRNPD, providing a post-transcriptional regulatory mechanism for H1.2 expression.\",\n      \"method\": \"MeRIP-seq, m6A inhibition, siRNA-mediated depletion of m6A readers (YTHDF2, IGF2BP1, hnRNPD), mRNA stability and translation assays\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, mechanistic pathway for H1.2 mRNA regulation but functional consequence on H1.2 protein activity not directly tested\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP7 deubiquitinase interacts with histone H1.2 and protects it from proteasome-mediated degradation; USP7-H1.2 interaction facilitates DNA repair in pancreatic neuroendocrine neoplasm cells.\",\n      \"method\": \"Proteomics, ubiquitin-omics, Co-IP, comet assay, γ-H2AX immunofluorescence, USP7 inhibitor (P005091), xenograft model\",\n      \"journal\": \"Science China. Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, functional DNA repair assays, in vivo model, single lab\",\n      \"pmids\": [\"41639524\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Histone H1.2 is a multifunctional linker histone that, beyond its structural role in chromatin compaction (acting as a dynamic liquid-like glue via multivalent electrostatic interactions), functions as a context-dependent gene-specific regulator: it represses transcription by forming complexes with YB1/PURα, binding p53 to block p300-mediated chromatin acetylation, interacting with pRb on E2F target genes, and recognizing EZH2-mediated H3K27me3 via its C-terminal tail; it also acts as a transactivator by bridging Cul4A and PAF1 to drive H4K31 ubiquitylation and productive elongation. In response to DNA double-strand breaks, H1.2 is released from chromatin in a p53-dependent manner (facilitated by PARP1-mediated PARylation and subsequent proteasomal degradation), translocates to the cytoplasm and mitochondria, and directly activates BAK through its C-terminal K/RVVKP motif to trigger cytochrome c release and apoptosis; it also forms an apoptosome complex with APAF-1 and CASP-9. DNA-PK phosphorylates H1.2 at T146 to dampen its repressive and pro-apoptotic activities, while ITCH E3-ligase polyubiquitinates H1.2 to suppress 53BP1-dependent DDR. H1.2 also participates in innate immunity by negatively regulating cGAS (recruiting TRIM28 for its degradation) and positively modulating MDA5/IRF3 signaling, and its genomic distribution is concentrated at low-GC, lamina-associated, H3K27me3-enriched heterochromatic domains.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Histone H1.2 is a linker histone that functions both as a structural organizer of chromatin and as a context-dependent regulator of transcription, the DNA-damage response, and apoptosis [#0, #33]. As a structural protein it universally localizes to the nuclear periphery and is enriched at low-GC, lamina-associated, H3K27me3-marked heterochromatic domains, where its depletion triggers global chromatin decompaction [#11, #33], and it establishes facultative heterochromatin in differentiating cells [#10]. Its N-terminal domain sets nucleosome-binding affinity while its C-terminal tail dictates the geometry of the globular-domain interaction and reads EZH2-deposited H3K27me3 to direct gene-specific recruitment and silencing [#8, #13]. H1.2 represses transcription through several routes: it assembles a YB1/PURα-containing complex that binds p53 and blocks p300-mediated chromatin acetylation at the Bax promoter [#4], forms a chromatin-bound complex with pRb to repress E2F target genes and enforce cell-cycle arrest [#16], and is deposited by BRG1 to silence progestin-repressed genes [#14]; conversely, it can act as a transactivator by binding Ser2-phosphorylated RNAPII and bridging the Cul4A E3 ligase and PAF1 elongation complex to drive H4K31 ubiquitylation and productive elongation [#9]. In response to DNA double-strand breaks, H1.2 is released from chromatin in a p53-dependent manner—facilitated by PARP1-mediated PARylation of its C-terminus and proteasomal turnover—and translocates to mitochondria where its C-terminal K/RVVKP motif directly activates BAK to release cytochrome c, and it further nucleates an APAF-1/CASP-9 apoptosome to drive apoptosis [#0, #17, #22, #2]. This activity is tuned by post-translational control: DNA-PK phosphorylates H1.2 at T146 to weaken p53 binding and dampen its repressive and pro-apoptotic functions [#7], while ITCH-mediated polyubiquitination of H1.2 suppresses RNF8/RNF168-dependent 53BP1 foci [#20]. H1.2 also stabilizes the transcription factors NRF2 and HIF-1α to support antioxidant and hypoxic adaptive programs [#26, #32], and contributes to innate antiviral responses by potentiating MDA5/IRF3 signaling while negatively regulating cGAS via TRIM28-mediated degradation [#31, #36].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that a linker histone is not merely structural but can transmit a nuclear DNA-damage signal to mitochondria, defining H1.2 as a specific apoptotic effector distinct from other H1 variants.\",\n      \"evidence\": \"Subcellular fractionation, isolated-mitochondria cytochrome c release, and H1.2-deficient mice after X-ray irradiation\",\n      \"pmids\": [\"14505568\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of Bak engagement not resolved at this stage\", \"How p53 directs H1.2 nuclear release left undefined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified H1.2 as a substrate of denitrase activity, a biochemical observation about its single tyrosine that remains peripheral to its chromatin functions.\",\n      \"evidence\": \"In vitro denitrase activity assay on chemically nitrated recombinant H1.2\",\n      \"pmids\": [\"12719531\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of H1.2 nitration/denitration not established\", \"Single in vitro study without cellular validation\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extended H1.2's apoptotic role beyond Bak by showing it positively regulates apoptosome assembly downstream of cytochrome c.\",\n      \"evidence\": \"Affinity labeling, mass spectrometry, and cell-free caspase activation reconstituting an H1.2/APAF-1/CASP-9/cytochrome c complex after UV\",\n      \"pmids\": [\"17618626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell-free study without in vivo confirmation\", \"Stoichiometry and direct binding interface with APAF-1 unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined H1.2 as a sequence-specific transcriptional repressor of the p53 program by reconstituting an inhibitory complex that blocks p300 acetylation.\",\n      \"evidence\": \"Affinity purification of an H1.2/YB1/PURα complex, in vitro chromatin transcription, Co-IP, and ChIP/RNAi at the Bax promoter\",\n      \"pmids\": [\"18258596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the same protein switches between repressor and apoptotic effector not addressed\", \"Genome-wide scope of YB1/PURα-dependent repression unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided in-cell evidence that H1.2 physically relocates to mitochondria and partners with Bak after DSBs, linking the 2003 release event to its mitochondrial target.\",\n      \"evidence\": \"Subcellular fractionation, Bak co-localization, and mitochondrial permeabilization assay after bleomycin\",\n      \"pmids\": [\"17879944\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding residues not mapped\", \"Single-lab imaging-based localization\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolved why H1 subtypes are non-redundant by showing H1.2 has an intrinsically distinct nucleosome-binding orientation governed by separable N- and C-terminal contributions.\",\n      \"evidence\": \"Domain-swap and point mutagenesis with dual-color FRAP in living cells\",\n      \"pmids\": [\"20444700\", \"22334665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the altered globular-domain geometry not solved\", \"Functional consequence for specific target genes not tested here\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapped cell-cycle-coupled phosphorylation of H1.2, hinting that PTMs target it to replication and transcription sites.\",\n      \"evidence\": \"Phospho-specific antibodies and immunofluorescence in synchronized HeLa cells\",\n      \"pmids\": [\"19609548\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Responsible kinase not identified\", \"Functional output of Ser172 phosphorylation undefined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified DNA-PK phosphorylation of H1.2 at T146 as a molecular switch that disrupts the p53–H1.2 interaction and de-represses p53-driven apoptosis.\",\n      \"evidence\": \"In vitro kinase assay, Co-IP, reporter assays, and apoptosis readouts with phospho-/acetylation-mimetic mutants\",\n      \"pmids\": [\"22249259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo regulation of T146 phosphorylation not established\", \"Crosstalk with the mitochondrial apoptotic function not examined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed H1.2 can act as a transactivator, bridging Cul4A and PAF1 to deposit elongation-promoting histone marks, demonstrating a positive role opposite to its repressive activities.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP for H4K31ub/H3K4me3/H3K79me2, and RNAi of H1.2/Cul4A/PAF1\",\n      \"pmids\": [\"24360965\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What determines repressor-versus-activator mode at a given locus unknown\", \"Direct catalytic relationship to Cul4A ubiquitylation not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated a developmental structural role: H1.2 builds facultative heterochromatin needed for rod photoreceptor nuclear integrity.\",\n      \"evidence\": \"Triple-knockout mice with electron microscopy, immunofluorescence, and nucleosomal repeat-length analysis\",\n      \"pmids\": [\"23645681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redundancy with H1e/H1(0) not fully separated\", \"H1.2-specific contribution within the triple KO not isolated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined H1.2's distinctive genome-wide distribution, anchoring its repressive function to low-GC, lamina-associated heterochromatic domains.\",\n      \"evidence\": \"ChIP-seq with variant-specific antibodies and HA-tagged variants in breast cancer cells\",\n      \"pmids\": [\"24476918\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism targeting H1.2 to LADs not addressed here\", \"Causality between enrichment and repression correlative\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified H3K27me3 recognition by the H1.2 C-terminal tail as the recruitment mechanism explaining its heterochromatin targeting and silencing.\",\n      \"evidence\": \"ChIP, H3K27me3-nucleosome binding assays, and C-terminal mutagenesis with gene-expression readout\",\n      \"pmids\": [\"26581166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mode of tail–H3K27me3 contact not solved\", \"Whether recruitment is direct or EZH2-coupled at all loci unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed targeted H1.2 deposition can be actively directed by a chromatin remodeler (BRG1) downstream of hormone signaling to repress specific promoters.\",\n      \"evidence\": \"ChIP, Co-IP, and knockdown with nucleosome positioning analysis at progestin-repressed genes\",\n      \"pmids\": [\"27390128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality beyond progesterone-responsive genes untested\", \"How BRG1 selects H1.2 versus other variants unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established H1.2 as a major pRb partner that augments pRb chromatin loading and E2F target repression, linking it directly to cell-cycle control.\",\n      \"evidence\": \"Reciprocal Co-IP, genome-wide pRb ChIP-seq, knockdown, and proliferation assays\",\n      \"pmids\": [\"28614707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether H1.2 acts upstream or downstream of pRb phosphorylation unclear\", \"Structural basis of the H1.2–pRb interaction undefined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected H1.2 to autophagy regulation via a SIRT1/HDAC1–H4K16ac–ATG axis in a disease (diabetic retinopathy) context.\",\n      \"evidence\": \"Overexpression/knockdown in cells, AAV in vivo overexpression, and siRNA in diabetic mice\",\n      \"pmids\": [\"28409999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect control of SIRT1/HDAC1 not separated\", \"Relevance outside retinal tissue untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed that PARP1-driven PARylation and degradation displaces H1.2 from chromatin to permit ATM activation, recasting H1.2 release as a regulated step in DSB repair signaling.\",\n      \"evidence\": \"Direct H1.2–ATM HEAT-domain binding, PARylation assay, PARP1 depletion, PARylation-dead mutant, and repair assays\",\n      \"pmids\": [\"29844578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between this displacement and the pro-apoptotic mitochondrial pool not reconciled\", \"PARylation site(s) not precisely mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Added an interaction-based repression mechanism via the mH2A1.2/HP1α/H1.2 module controlling immune-relevant gene silencing.\",\n      \"evidence\": \"Co-IP, ChIP, knockdown, and osteoclastogenesis assays in prostate cancer cells\",\n      \"pmids\": [\"29925860\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab, single-context observation\", \"Direct versus bridged H1.2–mH2A1.2 contact not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placed H1.2 at nucleolar organizer regions with UBF, implicating it in mitotic rDNA chromatin organization.\",\n      \"evidence\": \"UBF-Sepharose pulldown and imaging during mitosis and after rRNA synthesis inhibition\",\n      \"pmids\": [\"29301938\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role at NORs not tested\", \"Whether interaction is direct unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined ITCH-mediated polyubiquitination of H1.2 as an AKT-controlled brake on 53BP1-dependent DDR signaling.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, 53BP1 foci imaging, and AKT inhibition\",\n      \"pmids\": [\"30517763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitination sites on H1.2 not mapped\", \"Integration with PARP1-driven displacement not addressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Pinpointed the K/RVVKP motif as the minimal C-terminal determinant for direct BAK activation and cytochrome c release, providing the structural mechanism for H1.2's apoptotic effector function.\",\n      \"evidence\": \"In vitro cytochrome c release, K/RVVKP mutagenesis, direct BAK binding, and peptide competition\",\n      \"pmids\": [\"32786407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo requirement of the motif not tested\", \"Conformational change induced in BAK not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a lineage-specific role for H1.2 in granulopoiesis, where its loss redirects differentiation toward an eosinophil program.\",\n      \"evidence\": \"Genome-wide CRISPR screen, subtype KO, transcriptomics, and differentiation assays in human and mouse cells\",\n      \"pmids\": [\"32391789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes mediating lineage choice not pinpointed\", \"Overlap of H1.2 and H1.4 functions not separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked oncogenic K-Ras-ERK signaling to loss of H1.2 T146 phosphorylation via MDM2-mediated DNA-PK degradation, connecting H1.2 PTM control to tumor growth.\",\n      \"evidence\": \"K-Ras transfection, ChIP, phospho-mimetic mutant, and proliferation/migration assays in bladder cancer cells\",\n      \"pmids\": [\"31032946\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-study mechanistic chain\", \"Direct DNA-PK–MDM2 link not biochemically isolated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified an H1.2–STAT3 feed-forward loop driving hepatocellular carcinoma proliferation.\",\n      \"evidence\": \"Overexpression/knockdown, STAT3 ChIP at the H1.2 promoter, in vivo models, and STAT3 inhibition\",\n      \"pmids\": [\"35294987\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which H1.2 promotes STAT3 activation undefined\", \"Single-cancer-type context\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established H1.2 as a stabilizer of NRF2 that sustains glutathione synthesis, defining a feed-forward antioxidant cycle promoting NSCLC progression and chemoresistance.\",\n      \"evidence\": \"Co-IP, NRF2 ChIP at GCLC, H1c-KO/Kras mouse model, and ROS/GSH/cisplatin assays\",\n      \"pmids\": [\"37729198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether H1.2 acts on NRF2 in the nucleus or cytoplasm not fully resolved\", \"Direct binding interface not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated a metabolic role: H1.2 represses thermogenesis by activating Il10rα transcription in beige adipocytes.\",\n      \"evidence\": \"Adipocyte-specific KO mice, ChIP at Il10rα, and Il10rα rescue with cold-tolerance phenotyping\",\n      \"pmids\": [\"37414781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How H1.2 activates rather than represses this promoter not mechanistically explained\", \"Upstream signals regulating adipocyte H1.2 unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Added p16 repression by promoter-bound H1.2, with YB-1 sustaining H1.2 levels and recruitment.\",\n      \"evidence\": \"siRNA knockdown, ChIP, and qRT-PCR\",\n      \"pmids\": [\"37500167\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab ChIP-based study\", \"Senescence consequences not functionally tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed PTM-state of chromatin-bound H1.2 reshapes its proteome-wide interactome, including recruitment of DSB-repair factors.\",\n      \"evidence\": \"Chemically defined modified chromatosomes, affinity-MS interactomes, and in vitro ligation assay\",\n      \"pmids\": [\"37994785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In-cell relevance of identified interactors not validated\", \"Functional repair contribution beyond ligation assay untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked H1.2 to ALS pathology: PARylation-dependent FUS–H1.2 binding promotes mutant FUS aggregation and motor-neuron toxicity.\",\n      \"evidence\": \"iPSC-motor-neuron interactome, PARP1 inhibition, H1.2 perturbation, and C. elegans models\",\n      \"pmids\": [\"39167487\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether H1.2 acts in cytoplasm or via chromatin in this context unclear\", \"Direct FUS–H1.2 contact versus PARP1-bridged not separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended H1.2's transcription-factor stabilizing role to HIF-1α, supporting hypoxic adaptation.\",\n      \"evidence\": \"Co-IP with HIF-1α PAS domains, dimerization assay, PARP1 inhibition, and a knock-in mouse hypoxia challenge\",\n      \"pmids\": [\"39178313\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding interface not structurally defined\", \"Single-lab mechanistic chain\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a positive antiviral role through H1.2 potentiation of MDA5/IRF3 signaling against RNA virus infection.\",\n      \"evidence\": \"Overexpression/knockdown, Co-IP with MDA5 and IRF3, and IFN-β/viral assays\",\n      \"pmids\": [\"38399950\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect MDA5/IRF3 engagement unclear\", \"Single-study, single-virus context\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Confirmed H1.2's universal peripheral localization and its causal requirement for global chromatin compaction across cell types.\",\n      \"evidence\": \"Super-resolution microscopy and siRNA knockdown with quantitative decompaction readout\",\n      \"pmids\": [\"38530350\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What targets H1.2 to the periphery not addressed\", \"Relationship between compaction and gene-specific repression not bridged\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified Galectin-1 as a modulator that enhances H1.2 PARylation/degradation to favor ATM/NBS1 repair signaling over apoptosis in lung cancer.\",\n      \"evidence\": \"Proximity-labeling proteomics, Co-IP, PARylation assay, ATM/NBS1 phosphorylation, and in vivo tumor model\",\n      \"pmids\": [\"40365664\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Gal-1–H1.2 binding versus PARP1-mediated bridging unclear\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Defined H1.2 as a negative regulator of cGAS, both inactivating it on chromatin and recruiting TRIM28 for its nuclear degradation, with viral suppression of H1.2 unleashing IFN-I.\",\n      \"evidence\": \"Co-IP with cGAS/TRIM28, cGAS Lys240 activity assay, HSV-1 infection model, and Sp1 inhibition in vivo\",\n      \"pmids\": [\"41972757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct H1.2–cGAS contact versus chromatin-mediated effect not fully separated\", \"Single-study mechanism\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified USP7 as a deubiquitinase that stabilizes H1.2 to support DNA repair, adding a counterweight to ubiquitin-driven H1.2 turnover.\",\n      \"evidence\": \"Proteomics, ubiquitin-omics, Co-IP, comet/γ-H2AX assays, USP7 inhibition, and xenografts\",\n      \"pmids\": [\"41639524\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DUB site specificity on H1.2 not mapped\", \"Single-tumor-type context\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How H1.2 toggles between mutually opposed roles—structural glue, gene-specific repressor, transactivator, transcription-factor stabilizer, and cytoplasmic apoptotic effector—through its post-translational modification code and localization remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating chromatin and mitochondrial pools\", \"Structural basis of most direct protein interactions undefined\", \"In vivo hierarchy of competing PTMs (T146 phosphorylation, PARylation, ubiquitination, SUMOylation) not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [10, 33, 39]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 16, 9, 26, 32]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [22, 17, 26, 32]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [11, 27, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 11, 16]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [13, 33, 11]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 3, 22]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 12]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 2, 22]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [17, 20, 30, 41]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 9, 16]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [10, 13, 33]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [31, 36]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [26, 32]}\n    ],\n    \"complexes\": [\n      \"H1.2-YB1-PURα repressor complex\",\n      \"APAF-1/CASP-9 apoptosome\",\n      \"Cul4A-PAF1 elongation complex\",\n      \"pRb-H1.2 chromatin complex\"\n    ],\n    \"partners\": [\n      \"TP53\",\n      \"BAK1\",\n      \"RB1\",\n      \"PARP1\",\n      \"ATM\",\n      \"NFE2L2\",\n      \"ITCH\",\n      \"USP7\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}